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Abstract 
 
The physical structure of cellular membranes plays a critical role in lipid and 
protein sorting.  A novel biosensor was developed to probe the influence of curvature on 
sorting.  This biosensor mimics large, two-dimensional membranes in dynamic 
equilibrium, achieves high spatial resolution between curvature and molecules of interest, 
and has high sensitivity, enough for single particle detection.  The biosensor consists of 
continuous supported lipid bilayer formed over nanoparticles (40 to 200 nm diameter) 
deposited on a glass substrate.  The nanoparticles determine the extent of curvature.  This 
biosensor is the first to observe large-scale 2-dimensional diffusion of biomolecules on a 
supported lipid bilayer with small radii of curvature in equilibrium with flat areas of fluid 
bilayer.  This will allow correlation between protein function and the physical shape of a 
membrane.  Fluorescence microscopy was used to quantify spatial sorting of lipids and a 
protein relevant to cardiovascular disease, C-reactive protein (CRP).  Two lipids, 
fluorescein labeled hexadecanoic acid and 1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine, sense curvature by accumulating in areas over nanoparticles, and 
both are able to laterally exchange with surrounding lipids.  Dynamic fluidity of the 
bilayer was assessed using fluorescence recovery after photobleaching.  Lipids directly at 
sites of curvature recover more slowly than lipids over flat sections.  The spatial 
distribution of CRP was also assessed.  Curvature sensing of CRP is isoform dependent 
where native CRP does not sense curvature and modified CRP does sense curvature.  
 iii 
Finally, we show that a ribonucleic acid aptamer will bind specifically to modified CRP 
and not native CRP, enabling isoform specific studies of CRP to be conducted. 
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Chapter One: Introduction 
Membrane curvature plays an important role in several crucial cellular functions.  
Changes to membrane curvature are found everywhere from cell birth to cell death.  At 
mitosis, the central section of the cell pinches in, dividing the cell in half.  At cell death, 
the plasma membrane loses stability, increases permeability, and ejects apoptotic bodies 
into the intercellular space.  These mechanisms in the cell are complex and layered with 
confounding variables such as protein feedback loops, protein-lipid interplay, lipid 
domain formation, and much more.  The basic research presented here separates these 
variables to gain fundamental insight into the processes at work.  We investigate how 
lipids and proteins sort with regard to membrane curvature.  A novel biosensor was 
developed that separates curvature generation from other chemical aspects of cellular 
curvature, which enables us to probe the effects of curvature under controlled conditions.  
This resulted in new information regarding the curvature sensing properties of various 
lipids and a relevant cardiovascular marker, C-reactive protein. 
Biological Relevance of Membrane Curvature 
Membrane curvature is of particular interest in current biology (1,2,3,4,5,6,7,8,9).  
Changes to curvature can be seen during apoptosis, endocytosis, mitosis/meiosis, 
extracellular signaling, and many other cellular operations.  However, other chemical and 
physical changes occur during these operations, and often they are inseparable from 
curvature changes.  For example, during apoptosis several changes occur at the cellular 
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level.  The plasma membrane in particular undergoes multiple changes including 
increased permeability, changes to leaflet composition, oxidization of lipids, and the 
formation of areas of high curvature (10).  Fundamental understanding of cellular 
processes relies on the ability to separate these variables and to categorize their individual 
contributions to cellular activity.  Techniques capable of separating these variables from 
membrane curvature do exist, but each has its limitations.  In this introduction, I will 
establish the biological aspects of curvature and discuss model membrane systems that 
mimic curvature found in a cell.  These model systems served as the basis for our design 
as we sought to minimize disadvantages and 
maximize advantages in our system. 
Given the varied macroscopic processes that 
induce changes to curvature, it is not surprising to 
find areas of extreme membrane curvature 
throughout the cell interior.  Curvature can be 
transient, as in vesicle trafficking.  It can also be in 
more permanent structures like microvilli.  Figure 1 
is a graphic (2) that highlights the diversity of 
curvature within a typical cell.  The topology of a 
budding vesicle shows the different degrees of 
curvature.  Positive curvature creates a convex 
surface of interaction and has a larger surface area than a corresponding flat membrane.  
Negative curvature creates a concave surface of interaction with a smaller relative surface 
area.  Also note that if the bending surface is a bilayer, areas of both positive and 
Figure 1: Diagram detailing areas 
in the cell where extreme 
membrane curvature can occur.  
Figure used with permission (2). 
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negative curvature are present, but on opposite leaflets.  The terminology this work uses 
is to identify curvature based on the surface of interaction.  For example, a bilayer where 
a protein binds to the convex surface would be 
considered to have positive curvature, even 
though a concave surface exists on the non-
interacting face.  A budding vesicle (Figure 2 
(2)) is a good model process to consider for 
membrane curvature since it transitions through 
various radii of curvature (ROC), demonstrates 
both positive and negative curvature, and at one 
point has a saddle which includes both positive 
and negative curvature on the same interacting surface. 
These changes to surface area are the main driver for the characteristic instability 
of lipids in curvature.  On the negative face, lipid head groups are forced together and 
strong electrostatic forces repel the head groups from each other.  The positive face 
forces exposure of the hydrophobic tails to the aqueous solution creating entropic 
instability.  This lipid crowding on the negative face, and the corresponding hydrophobic 
exposure on the positive face, cause instability in the curved structure.  These 
energetically unstable structures must be 1) maintained by proteins which stabilize the 
strained morphology, or 2) accommodate a different leaflet ratio of lipids or different 
types of lipids. 
Apoptotic bodies and budding vesicles are ideal examples of membrane 
curvature.  Apoptosis is the process of programmed cell death and has several purposes in 
Figure 2: Schematic of a budding 
vesicle shows varying extents of 
curvature present during this process.  
Figure used with permission (2) 
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the body, such as maintaining homeostasis and as an immune response (10).  During this 
process, the cells shrink in size, become more dense and irregular in shape.  The plasma 
membrane begins to bleb severely.  These blebs later entirely release from the dying cell 
as apoptotic bodies.  The membranes of these bodies remain intact and are later absorbed 
by surrounding macrophages or other cells where the contents of the bodies are recycled.  
As a reference for size, endothelial cells create apoptotic bodies with radii of curvature 
from 500 nm to 2 μm.  Smaller ejections (microparticles) were also observed (11). 
Comparatively, vesicle sizes are typically much smaller, with radii on the order of 
10s to 100s of nanometers.  This transport is the primary mechanism in cells to transfer 
proteins between compartments of the endomembrane system and the plasma membrane, 
and a primary mechanism for ingesting new material via endocytosis.  Due to the large 
extents of curvature, these vesicles are often accompanied by coat proteins which help 
stabilize the unfavorable extreme curvature.  Triggering of the vesicle formation usually 
accompanies recruitment of cargo via receptor molecules.  After reaching a destination, 
these coat proteins detach, making the vesicle more fusogenic and easily incorporated 
into the destination membrane (12,2). 
Causes of Membrane Curvature 
For a membrane to maintain a given structure in the face of this strained 
morphology, lipid composition and protein coating change to counter and minimize the 
energetic cost of bending.  These two broad effects are not independent from each other, 
but are discussed here separately for simplicity.  A minor contribution to curvature comes 
from the physical or molecular shape of the lipid (5).  A typical saturated lipid like 
phosphotidylcholine is cylindrical in shape, and this will stabilize zero curvature or a flat 
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membrane.  As a flat membrane begins to curve, defects appear in the positive face (13).  
A defect is a point in the membrane where the hydrophobic tails are exposed to aqueous 
solvent, and this arises due to the increase in surface area of the positive face.  These 
defects are stabilized by inverse conical lipids, such as lysolipids or certain dye labeled 
lipids.  On the negative face of a curving membrane, head groups are forced closer 
together due to the reduction in surface area.  This steric hindrance is eased by conical 
lipids like phosphatidic acid.  The smaller head group and broader tail region help ease 
the steric interaction between neighboring lipids.  Differences in numbers of lipids 
between the two leaflets also act to stabilize highly curved surfaces.  In a liposome with 
50 nm on the outer diameter and a thickness of 5 nm, the ratio of lipids on the outer 
leaflet to inner leaflet is 1.23 (2).  Lipids also tend to form domains that have bending 
rigidity that hinder or assist in curvature formation.  Cylindrical lipids tend to form 
ordered domains with high bending 
rigidity, whereas conical and inverted 
conical lipids form disordered domains 
with low rigidity.  Though individual 
lipids have a small contribution to 
overall curvature formation, curvature 
could influence the formation of 
domains and further stabilize the 
presence of domains (7).  All of these 
changes assist or hinder morphology directly, but certain lipids also act as sites for 
protein binding, which can further influence curvature stability. 
Figure 3:  Crystal structure of a BAR dimer 
with a proposed bilayer conforming to the 
intrinsic shape.  When a bilayer is fitted well to 
the shape of the protein, more electrostatic 
interactions are present, thus increasing 
binding.  Figure used with permission (2). 
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Proteins have several methods to influence 
curvature.  1) Scaffolding is common in the cell and 
functions by having a rigid protein structure conform 
to and support a new membrane structure.  Some 
common examples of scaffolding proteins are clathrin, 
the dynamin family, and caveolin (14,15,16,17).  2) 
Many proteins incorporate BAR (Bin-Amphiphysin-
Rvs) domains, dimer domains that have a distinctive 
banana shape.  These domains, seen in Figure 3 (2), 
will sense curvature at low concentrations (18).  When 
the curvature of the membrane matches the intrinsic 
curvature of the dimer, there is tighter binding.  It is 
expected that the binding energy of BAR domains to 
curvature matches the energy required to bend the 
membrane, as has been seen with amphiphysin (19).  
3) Commonly operating alongside BAR domains are 
amphipathic helices, in which the helix is attached to the N-terminus of the BAR domain 
(the combination dubbed N-BAR).  These protein domains will insert into a membrane 
and increase the surface area and thus generate positive curvature.  Figure 4 (2) shows the 
wedge effect that generates the curvature.  The α-helix structure has one face that is 
hydrophobic and one face that is positively charged.  The hydrophobic face inserts into 
the tail section of the membrane while the positive face interacts with the head group 
region (20).  The one-sided insertion causes the surface area asymmetry.  4) 
Figure 4: Schematic of a bilayer 
rearranging to accommodate an 
inserted amphipathic helix.  One 
side of the helix is hydrophobic 
while the other is positively 
charged.  Figure used with 
permission (2). 
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Microfilament (actin) and microtubule (tubulin) activity can deform the membrane 
through changes in bilayer tension (21,22,23).  It is interesting to note the complex 
interplay that occurs between these mechanisms through tension.  The cytoskeleton is 
responsible for maintaining and changing tension, which causes a response in 
microtubule activity, which affects both tension and feeds back to the cytoskeleton 
activity (24).  The cytoskeleton also plays a secondary role in morphology changes by 
directing vesicles to sites of fusion and endocytosis. (25)  5) The final mechanism 
responsible for membrane deformation is the presence of transmembrane proteins.  These 
proteins will typically prefer curvatures that mold around their shape.  While this 
mechanism is known to exist, such as with the voltage dependent K
+
-channel (26), not 
much is broadly known about this effect since the structures of transmembrane proteins 
remain elusive. 
History of Fluorescence 
The biosensor was designed with fluorescence microscopy in mind.  This method 
is extremely useful when studying biological systems, which we intend to mimic.  
Fluorescence is a subcategory of luminescence, which is defined as “a spontaneous 
emission of radiation from an electronically excited species (or from a vibrationally 
excited species) not in thermal equilibrium with its environment.” (27).  Fluorescence, 
along with phosphorescence and delayed fluorescence, is a type of photoluminescence.  
These forms of luminescence arise from excitation due to photon absorption and are 
distinct from other excitation modes, like chemiluminescence and bioluminescence (27). 
The first observation of fluorescence can be attributed to Spanish physician 
Nicolás Monardes (28) in 1565.  He reported a blue color from an infusion of Mexican 
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wood used to treat urinary diseases.  This infusion was rare, thus making it a target of 
counterfeiting.  Dr. Monardes used the blue color as a method of detecting false infusions 
(28).  After Dr. Monardes, others noted similar color inconsistencies from natural 
substances: 1) the dichroic nature of fluorite by Edward Clarke in 1819 (29), 2) again 
fluorite by René-Just Haüy in 1822, who (incorrectly) identified the phenomenon as light 
scattering (opalescence) (30), and 3) red color from chlorophyll extracts by Sir David 
Brewster in 1833 (31).  A major breakthrough in understanding fluorescence came in 
1845 by Sir John Herschel.  He was the first to note fluorescence from a single substance, 
not a natural extract (32).  Herschel used a prism to illuminate an acid solution of quinine 
sulfate with blue light (33) to observe emitted light in the blue, green and yellow regions.  
He failed to note that the emitted light was longer wavelength than the illumination light, 
and thus attributed the phenomenon, like his predecessors, to scattered light.  This crucial 
observation would ultimately be made by George Stokes. 
A turning point in understanding fluorescence, and coining of the term, came 
from Sir George Gabriel Stokes in 1852.  Stokes continued studying quinine solutions 
and fluorite crystals, but he made the important observation that emitted light is always 
longer wavelength than absorbed light (34).  Using more sophisticated methods than 
Herschel, Stokes used a prism to separate solar radiation and illuminated a solution of 
quinine.  In the visible region, nothing happened.  When the tube was placed beyond the 
violet region of the spectrum in the ‘invisible rays’ as Stokes describes it, the solution 
glowed blue.  He called it “…literally darkness visible.” (34)  Though in his first work 
Stokes continues the tradition of referring to the phenomenon as a derivative of scattering 
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(in his work, he uses the term dispersive reflection), he admits in a footnote his dislike of 
the term, and he coins the term fluorescence: 
I confess I do not like this term.  I am almost inclined to coin a word, and call the 
appearance fluorescence, from fluorspar, as the analogous term opalescence is 
derived from the name of a mineral. (34) 
The red-shift that normally accompanies fluorescence is now known as the Stokes law or 
Stokes shift in honor of Stokes’s contribution.  It is useful to note that Edmond Becquerel 
also observed a red shift of emitted light from calcium sulfide when illuminated with UV 
light in 1842, 10 years earlier than Stokes (35,32).  Becquerel even filed a priority claim 
against Stokes (36,32) for this observation.  However, a primary difference is that 
Becquerel observed phosphorescence, not fluorescence, and Becquerel misinterpreted 
Stokes’s observations as short-lived phosphorescence, disregarding the introduction of 
Stokes’s ideas of the separate phenomenon fluorescence. 
The next major advancement in understanding fluorescence came in the late 19
th
 
century, along with other observations about the breakdown of classical mechanics and 
the paradigm shift into quantum mechanics.  Eilhard Wiedemann postulated scenarios 
where the Second Law of Thermodynamics was violated.  Fluorescence appeared to 
allow energy to flow from cold objects to hotter objects (37,38).  Additionally, several 
physicists, including Franz Stenger in 1886 (39,32) and Ernest Merritt in 1904 (40), noted 
observations where the Stokes law was violated and shorter wavelength fluorescence was 
observed.  A clue was noted by Lommel in 1878 who observed this apparent violation 
only occurred when absorption and fluorescence curves overlap (41). Resolution to this 
paradox finally came with Planck theory of quanta and Albert Einstein’s use of this 
theory for luminescence.  He proposed that the curves observed in fluorescence suggest a 
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statistical process, and that the violation of the Stokes law occurs because the molecular 
vibration supplies the additional energy needed to blue shift emission.  This would satisfy 
both the First and Second Laws of Thermodynamics.  Joseph von Kowalski later proved 
this in 1910 by showing the violation of the Stokes law for rhodamine is larger at higher 
temperatures, consistent with Einstein’s calculations (42). 
Modern understanding of fluorescence is derived from the work of Francis Perrin 
in 1922 (43) and Aleksander Jablonski in 1935 (44,45).  Perrin introduced what is 
commonly referred to now as the Jablonski diagram, which included a mechanism for the 
Stokes shift and a metastable state.  The metastable state was an attempt to describe long-
lived fluorescence and phosphorescence.  However, Perrin did not include a path for 
radiative transfer from this metastable state back to the ground state.  Jablonski provided 
this information to the diagram, thus cementing his namesake (45).  The distinction 
between fluorescence, a retention of spin multiplicity, and phosphorescence, a change in 
spin multiplicity, was made by Terenin in 1943 and Kasha in 1944 (45). 
Fluorescence has several uses in the modern scientific fields of chemistry, 
physics, and medicine (45,46).  Of particular note for this work is the application of 
fluorescence recovery after photobleaching (FRAP) to microscopy of supported lipid 
bilayers.  Fluorescence microscopy was first used in 1942 by Coons, Creech, Jones and 
Berliner to observe fluorescent antibody distribution in mouse tissue (47).  From that, cell 
surface staining was done in 1974 (48), proteins in live cells were seen in 1978 (49), and 
intrinsic fluorescence (unlabelled protein) imaging done in 1995 (50).  Lateral diffusion 
of objects in a membrane was best described theoretically by Saffman and Delbrück in 
1975 (51) as cylindrical objects diffusing freely in 2 dimensions.  Experimental work to 
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observe lateral diffusion can be done by FRAP, and the most complete description of this 
method is given by Axelrod, Webb, and coworkers in 1976 (52).  For supported lipid 
bilayers, an excellent mimic of 2-dimensional membranes, pioneering work into creation 
and characterization has been done by Tamm (53,54) and McConnell (54). 
FRAP has been used extensively to characterize biological dynamics.  The 
publication by Axelrod, Webb, and coworkers (52) has been cited over 1900 times as of 
this writing (55).  In 1982, Webb and coworkers showed that constraints to lateral 
diffusion of lipids and receptor molecules are relaxed in blebs of muscle cell membranes 
(56).  The diffusion of voltage-dependent sodium channels is restricted to the axon 
hillock of neurons with no diffusion to the cell body.  This was shown using FRAP in 
1988 by Elson and coworkers (57).  FRAP has played a crucial role in studying the 
presence of lipid domains in cells (58,59,60,61), a topic that remained controversial 
throughout the 1990s and into the 2000s.  In recent medical research, FRAP has been 
used to study interstitial transport of drugs across cancerous tumor boundaries toward 
target cells (62), identify an association of influenza viral proteins with membrane rafts 
(63), and image the transcription cycle of HIV-1 (64).  Assays including fluorescence 
remain an integral part of the analytical toolkit used to study biologically interesting 
phenomena. 
The State of the Art in Membrane Curvature Sensing 
To get an understanding for the state of the art in curvature sensing assays, I will 
highlight four different methods already established.  As discussed earlier, separating 
curvature from confounding variables within a cell is difficult.  All of these methods seek 
to control curvature through a variety of variables that mimic cellular conditions.  By 
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discussing these methods and their advantages/disadvantages, I will highlight how the 
present work maximizes the advantages, minimizes the disadvantages, and introduces 
new capability beyond what is already known.  This biosensor is the first to observe 
large-scale 2-dimensional diffusion of biomolecules on a supported lipid bilayer with 
small radii of curvature in equilibrium with flat areas of fluid bilayer.  This enables 
unprecedented observation of the influence of physical structure on dynamic sorting. 
Liposomes can be particularly useful in curvature investigations because they 
have a single defined curvature determined by the diameter of the vesicle.  Liposomes 
have been used as models for biological membranes (65).  A more recent assay, the 
single liposome curvature (SLiC) assay, tethers liposomes to a glass surface with 
sufficiently low density to resolve individual vesicles (66).  Figure 5a (3) schematically 
demonstrates this method.  These liposomes are labeled with fluorescent lipids, such as 
Texas Red DHPE, and the relative fluorescence used to determine size.  Using a second, 
spectrally separated fluorophore on a protein of interest, the amount of binding can be 
Figure 5: Details of the SLiC assay.  A) Isolated liposomes are immobilized on a glass 
surface with biotin/streptavadin.  B) Confocal image of a heterogeneous sample.  Scale 
bar is 10 μm.  C) Total integrated fluorescence for the liposomes indicates size.  D) 
Binding molecule fluorescence over the same area as C.  To normalize for the size of 
the liposome, the density of the binding molecule is calculated by dividing integrated 
intensity in D over C.  Scale bar in C and D is 1 μm.  Figure used with permission (3). 
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quantified.  Figures 5b-c show an example confocal image and the ratio used to 
determine curvature sensing molecule density.  In this study (3), researchers used this 
method to investigate amphipathic motifs binding to curvature.  They revealed that 
binding is mediated by number of binding sites, not increased affinity as would be 
predicted.  The primary advantage of this system is that it uses single liposomes, which 
illuminates more population information than ensemble studies.  A major disadvantage is 
that the different radii of curvature are isolated.  This eliminates dynamic exchange of 
bound motifs along the surface, which does not mimic membranes in organelles or the 
plasma membrane. 
Following a different track with using liposomes, another method takes giant 
unilamellar vesicles (GUV) and pulls out long tubes via micropipette aspiration (67).  As 
a tube is pulled from the GUV, the size of the tube is determined by the rigidity of the 
bilayer and the pulling force exerted on the tube.  More rigid bilayers lead to larger tubes, 
and increasing the pulling force decreases the size of the tube.  The radius, R (m),  of 
these pulled tubes is described by the bending rigidity of the bilayer, κ (N·m), and 
membrane tension, σ (N/m), as  
                (Eqn. 1) 
Tension then is dependent on the pulling force, f (N), as  
                 (Eqn. 2) 
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Therefore, by controlling the pulling 
force, the radius can be controlled (59).  Figure 6 
(59) is a brightfield image of this method in 
action.  The researchers here were able to study 
lipid sorting into ordered and disordered phases 
and the ability of those phases to form tubes.  
After studying rigidity of these phases, the 
experimenters verified the assumption that tubes 
are typically pulled out of disordered, less rigid 
phases.  A second study with this method (9) was 
able to demonstrate N-BAR domains ability to 
sense curvature at low concentrations but 
generate curvature at higher concentrations.  A 
major advantage of these methods is that it 
mimics curvature changes induced by 
cytoskeletal activity (59).  Secondly, tension can 
be used not only as an inducer of curvature, but 
a sensor for curvature changes, as in the second 
study (9).  Disadvantages of this method include the need for specialized equipment, the 
limited ability for lipids to exchange with the ‘bulk’ GUV (9), and like the liposome 
method, a failure to mimic curvature on large-scale, 2-dimensional surfaces such as the 
plasma membrane in the areas imaged, the extended tube.  Additionally, only ensemble 
dynamics through fluorescence recovery after photobleaching (FRAP) are accessible in 
Figure 6: A GUV is aspirated to a 
pipette on one end and attached via 
biotin/streptavidin to a bead trapped 
in optical tweezers on the other.  In 2-
3, the GUV is gently withdrawn and a 
tube is formed between the GUV and 
the bead.  The tension on the pipette 
controls the size of the tube.  The 
scale bar is 10 μm.  Figure used with 
permission (59). 
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this method due to the large percent 
fluorescent lipid needed (1%), thus single 
particle tracking is not possible. 
Mimicking this large-scale, 2-
dimensional surface is the primary advantage 
of the final two methods presented.  Using 
soft lithography, researchers were able to 
pattern glass with a regular, wavy surface.  
Figure 7 (4) demonstrates the topography of 
this setup.  Lipids are added via liposome 
deposition, a standard supported lipid bilayer 
(SLB) technique.  Using atomic force 
microscopy (AFM), the glass surface 
curvature is characterized, which in this 
study had a maximum radius of curvature of 
55nm.  The SLB molding around the surface 
waves is assumed.  The wavy nature of the surface allows a continuous transition from 
positive curvature to negative curvature.  Fluorophore labeled proteins are visualized with 
confocal microscopy and correlated to the AFM images.  Mimicking 2D surfaces, 
transitions between extents of curvature, and presence of a large reservoir of lipids are 
major advantages of this method.  This method also clearly creates areas of negative 
curvature.  Preparation of the surface is the major disadvantage.  Preparation requires 
harsh surface etching (HF, NH4F, CF4, and O2 plasma), high temperatures (200°C), and a 
Figure 7: Topography of glass surface 
taken.  A) Schematic cross-section 
showing relevant distances.  B) Widefield 
image of the surface.  C) AFM image (note 
scale change).  D) Surface profile of C.  
The inset shows the change in curvature 
corresponding to the boxed area.  Figure 
used with permission (4). 
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prefabricated polydimethylsiloxane mold.  The requirement of this mold makes changing 
the surface topology in multiple experiments non-trivial.  Additionally, the process of 
determining curvature is separate from the process used to investigate protein location 
and motion.  This requires an additional method to correlate the two.  This work 
interestingly found curvature sensing properties of various proteins (ENTH, N-BAR, and 
CTB) when the bilayer was saturated, yet single-molecule imaging showed no curvature 
sensing.  This implies a cooperative aspect to curvature sensing. 
The final established method I highlight also uses lithography to pattern a glass 
surface with curved morphology (60).  Charged polymer nanoparticles (NPs) will self 
assemble into ordered arrays on an oppositely charged glass surface.  Subsequent thermal 
treatment will anneal the particles and systematically change the radius of curvature of 
the particles with respect to the treatment time.  An SLB can be formed over this 
structured surface via liposome deposition.  Figure 8 (8) shows scanning electron 
micrographs of the top (a) and side (b-d).  Using FRAP, the researchers observed various 
diffusion constants of bilayers over the patterned surfaces.  Contrary to expectation, they 
Figure 8: Series of SEM images showing a sensor made from colloidal lithography.  A) 
Overhead image of 110 nm particles heated at 110°C.  B-D are side views of the 
particles and show the effect of higher temperatures, which causes the radius of 
curvature to decrease.  B) 110°C  C) 114°C  D) 118°C.  Figure used with permission 
(8). 
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found that more highly curved bilayers had larger diffusion constants.  The authors 
speculated that alleviating of packing constraints at sites of positive curvature was 
responsible for increased diffusivity.  This method is able to easily control the radius of 
curvature via temperature and simulate a 2D surface.  Curvature was not correlated to the 
spatial organization of the lipids though.  Nanoparticles were not fluorescent nor was 
correlated AFM done, so the influence of curvature at specific sites could not be 
investigated.  Without this, only the general effect of curvature, and not the spatial, 
morphological influence, can be investigated. 
Through our efforts, we seek to further understand the transient interactions 
between regions of membrane curvature and proteins/lipids.  We characterize protein and 
lipid sorting to curved surfaces, lateral movement, colocalization with pertinent features, 
and isoform effects.  To accomplish this, we have developed a novel biosensor that 
mimics biological membrane curvature, and demonstrates the application of the biosensor 
to various lipids and a protein suspected of curvature sensing properties, C-reactive 
protein (CRP).  This new biosensor has notable advantages over the sensors currently in 
use.  1) Most notably, this biosensor spatially resolves the interaction between protein, 
lipid, and sites of curvature.  It mimics the surface of blebs and budding endocytoic 
vesicles by having isolated sites of curvature in dynamic equilibrium with a bulk, flat 
bilayer section.  2) The preparation is quick and simple.  3) Due to the independently 
resolved extents of curvature, our system can have inherent heterogeneity.  This 
heterogeneity permits molecules of interest to sort dynamically into regions of curvature 
with a high degree of specificity.  This gives us refined information about molecular 
sorting.  4) Chemical composition of the bilayer is controlled independently from the 
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curvature generating mechanism.  5) The sensitivity of the biosensor is high enough to 
detect single molecules moving on the surface. 
This dissertation is divided into six chapters.  Chapter two describes the methods 
and materials used to conduct the experiments.  Some terminology is also discussed. In 
chapter three, we discuss data from characterization of the biosensor and control 
experiments conducted.  Chapter four focuses on the implications of lipid sorting into 
curved SLBs and the diffusion of curvature sensing lipids.  Chapter five discusses our 
investigations into CRP conformation conversions and curvature sensitivity.  Finally, 
chapter six summarizes the major results. 
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Chapter Two: Methods 
Formation of the biosensor was a modification of established supported lipid 
bilayer (SLB) techniques (61).  Lipid composition was controlled at the time of SLB 
preparation, and this was separate from preparation of the physical shape of the surface.  
Surfaces were prepared by a rigorous cleaning method and colloidal deposition of 
polystyrene nanoparticles (NPs) onto a glass substrate.  SLBs were formed around the 
NPs which caused the bilayers to conform to the NP surface, thus inducing a desired 
curvature.  In future uses of this sensor, proteins and molecules of interest can be added 
after SLB is formed.  This dissertation includes a proof of this concept using C-reactive 
protein (CRP). 
In this chapter, we describe the methods used to create and characterize the 
biosensor.  The primary methods were microscopy techniques (total internal reflection 
and confocal fluorescence), but other fluorescence techniques were also used to 
supplement microscope images.  These methods were used to assess fluidity of bilayers 
and to perform controls.  These results show our system is congruent with work presented 
in literature. 
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Protocol for Biosensor 
Formation 
Films were prepared by 
mixing the relevant lipid 
combination in chloroform.  Our 
typical lipid composition 
consisted of 98% 
phosphatidylcholine (PC) lipids 
harvested from soy (Soy-PC), and 
2% fluorescent lipid, percentages 
by mole.  We primarily use three 
fluorescent lipids: Marina Blue - 
1,2-Dihexadecanoyl-sn-Glycero-
3-Phosphoethanolamine (MB-
DHPE), Fluorescien - 1,2-
Dihexadecanoyl-sn-Glycero-3-
Phosphoethanolamine (Fl-DHPE), and Fluorescien hexadecanoic acid (Fl-HDA).  
Structures of these lipids are shown in Figure 9a-c, respectively.  Soy-PC includes a 
distribution of tail lengths and degrees of unsaturation. A typical carbon-to-degree of 
unsaturation distribution of tails is 16:0 (14.9%), 18:0 (3.7%), 18:1 (11.4%), 18:2 (63%), 
18:3 (5.7%), and unknown (1.3%) (Avanti Polar Lipids, Lot 840054).  The structures of 
the lipids in this mixture are shown in Figure 10a-e, respectively.  Stock lipids were 
Figure 9: Molecular structures of the three dye-
labeled lipids used in this work.  A) MB-DHPE, B) 
Fl-DHPE, and C) Fl-HDA 
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dissolved in chloroform and stored until use at approximately 10 mM concentration.  
Total number of moles for each film was 250 nmol.  Appropriate volumes to obtain the 
98:2 mole ratio were mixed in filtered chloroform and vacuum dried overnight to 
evaporate the chloroform.  Other lipid mixtures could also be obtained by adjusting the 
98:2 ratio as needed. Films were then stored for 3-4 months under nitrogen at -20°C.  
Chloroform was filtered through alumina and stored at -20°C prior to use with any lipid.  
Inorganic chemicals were purchased from Sigma-Aldrich, lipids from Avanti Polar 
Lipids, and biological chemicals and proteins from Life Technologies. 
Surfaces were prepared via rigorous cleaning and patterned using NPs prior to 
SLB formation.  8-well dishes were purchased from Lab-Tek (#1.0 or #1.5 glass).  First, 
both sides of the glass plate were immersed in 0.1% sodium dodecylsulfate (SDS, w/v) 
for one hour.  Second, both sides were immersed in 1.0% bleach solution (v/v) overnight.  
Slides were stored under millipore water for up to 1-2 months.  This pre-cleaning is 
necessary to remove larger contaminants, such as dust and oils.  Immediately prior to use, 
the upper surface was covered in 100μL of 2% Hellmanex (v/v, a proprietary alkaline 
cleaning solution from Hellma Analytics, Müllheim, Germany) for one hour.  At this 
point, the glass was further patterned using NPs or used for SLB formation as a flat 
surface. 
In this work, three sizes of polystyrene NPs were used: 40 nm, 100 nm, and 200 
nm in diameter (Life Technologies).  For imaging, NPs were diluted to a level where NPs 
were not clustered.  Dilutions used were 1x10
-6
, 1x10
-4
, and 1x10
-3
, by volume from 
stock, respectively.  Initial stock concentrations were 1% (w/v) solids.  This resulted in 
 22 
approximate bead dilutions for 40, 100, and 200 nm beads as, respectively: 7x10
8
, 4x10
9
, 
and 5x10
9
 beads/mL.  Dilutions were made in a deposition buffer consisting of 30 mM 
HEPES, 2 mM CaCl2, and 140 mM NaCl at pH 6.4.  Diluted NPs were incubated in the 
wells for 15 minutes, and then the solution was removed.  NPs were adhered only lightly 
to the surface, so we did not rinse.  A linker molecule to facilitate NP attachment is not 
recommended, as this will interfere with bilayer fluidity (Figure 14).  This preparation 
was sufficient for NPs to act as patterns for SLB formation and curvature. 
We used the following procedure to create fluid SLBs.  A dried film, typically 
250 nmol, was immersed in 2 mL of deposition buffer and sonicated for 15 minutes using 
a probe sonicator on low power.  The sonicator consisted of a Fisher Prove Dismembrator 
Model 100 attached to an Ultrasonic Convertor probe head (Serial number: FS3406).  
Pulsed sonication for 0.1s on and 0.1s off was also used to prevent heat buildup.  This 
method creates a heterogeneous mixture of unilamellar and multilamellar vesicles that 
will adhere to glass and rupture, forming a lipid bilayer over the glass.  This method 
forms a single bilayer over the glass surface (Figure 19).  After sonication, 100 µL of the 
vesicle solution was added to NP prepared wells and incubated for 1 hour at 37°C.  The 
surfaces were then cleaned of excess liposomes by sequentially adding 100 µL of 
Figure 10: Molecular shape of the dominant species in soy PC and major constituent 
of supported lipid bilayers. 
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deposition buffer, then removing 100 µL.  This process left the surface wet at all times, 
and was repeated a total of three times.  The SLB was formed and ready for direct 
imaging, or for addition of protein.  If CRP was added, 100 µL of deposition buffer was 
accounted for as a dilution factor. 
To prove this method creates only a single bilayer, fluorescence of 1-palmitoyl-2-
[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)-amino]dodecanoyl]-sn-glycero-3-
phosphocholine (NBD-POPC) can be quenched using sodium dithionite.  This procedure 
has been done previously using bilayers formed around silica nanoparticles (68).  The 
SLB was formed in 8-well plates as usual over a surface without NPs with 100 μL of 
deposition buffer in the well.  10 mM sodium dithionite was prepared in deposition 
buffer.  One frame prior to dithionite addition is taken to get a baseline of fluorescence.  
10 μL of dithionite solution (to a final concentration of 5 mM) was added to each well 
and quickly mixed by pipetting up and down.  The first image after addition was taken as 
quickly as possible, approximately 20 seconds after addition.  Five additional images 
were taken at 1 minute intervals.  This prevents photobleaching of NBD and allows for 
refocus to prevent microscope drift.  Mean intensity of fluorescence was measured in a 
10μm x 2μm box positioned to avoid liposomes.  The curve was normalized to the 
intensity before addition of dithionite solution. 
Preparation of mCRP 
Modified CRP (mCRP) was prepared in three ways.  Native CRP is purchased 
purified from human serum from Academy Biomedical Co.  The first two methods, urea 
and heat, denatured CRP to similar molecular weights (MW) when run on a native gel; 
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both run at smaller MW than native CRP (pCRP) and higher MW than fully denatured 
CRP (69).  All three methods have similar denaturing curves in fluorescence assays.  In 
the first method, pCRP was treated with heat and SDS (mCRP in most sections, 
mCRPSDS in section: Aptamer Specific to mCRP).  pCRP was diluted to a desired 
concentration (typically 1μM) in 0.01% SDS in deposition buffer.  This was heated at 
80°C for 1 hour.  In the second method, pCRP (typically 1μM) was put in a solution of 
8M urea and 10 mM EDTA and incubated at 37°C for 2 hours.  Then using 3500 MW 
cutoff (MWCO) dialysis tube, mCRP was dialyzed against 2 L PBS at 4°C for 2-3 hours.  
We repeated dialysis a total of 3 times.  The final dialysis was run overnight.  When 
needed, mCRP was concentrated using a 10k MWCO, spun at 5000G for 10 minutes.  In 
the final method, using guanidine hydrochloride (GndHCl), pCRP (typically 1 μM) is 
incubated with 1M GndHCl for 90 minutes at 37°C.  These conditions were selected 
because we observed efficient conversion to mCRP via gel electrophoresis analysis. 
A fourth treatment to modify CRP was also done using HCl, though this CRP 
isoform does not bind C1q.  pCRP was incubated in an acidic solution (10 mM 4-(2-
hydroxyethyl)-1-piper-azineethanesulfonic acid (HEPES), 0.1 M HCl, pH 2) for 5 min 
and neutralized with 0.1 M NaOH.  A detailed explanation for the use of this isoform is 
in the section: Aptamer Specific to mCRP, and this isoform is refered to as mCRPHCl. 
CRP–aptamer complexes were prepared by incubating the relevant CRP isoform 
with RNA aptamer in binding buffer (20 mM HEPES, 140 mM NaCl, 50 mM KCl, 0.1 
mM DTT, and 5% glycerol at pH 6.5).  Incubation was carried out at room temperature 
for 20 min and analyzed immediately.  While calcium is not necessary for aptamer 
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binding, 2 mM CaCl2 was added to the pCRP sample to retain its folded pentameric 
structure. 
Typically in studies on CRP, this conformational change is often refered to as an 
“isoform change” (70) (71) (72) (73).  This work will continue the use of this 
terminology, though we recognize that the use of “isoform” is slightly incorrect.  The 
term typically refers to similar proteins resulting from different genes or through 
alternative gene splicing (74).  Technically, the change to CRP discussed here is a 
conformational change. 
Polyacryalmide Gel Electrophoresis 
Native polyacrylamide gel electrophoresis (native PAGE) was used to determine 
the isomeric state of CRP.  Denaturing gels cannot be used, as they denature pCRP, 
causing it to run at a similar position as mCRP.  The procedure to pour a native 10% 
polyacrylamide gel follows.  We prepared a gel apparatus with thickness of 1 mm.  For 
the resolving gel, we mixed 3.35 mL of 30% bis-acrylamide (29:1) solution, 2.5 mL 
1.5M Tris (pH = 8.8), and 5 µL 10% (w/v) SDS in a 15 mL tube.  This was filled to 10 
mL, vortexed, and then we added 10 µL TEMED and 100 µL 10% APS.  This final 
mixture was quickly poured into gel apparatus.  We covered the wet gel with a small 
amount of ethanol and let it stand for 1 hour.  Afterwards, we poured off ethanol before 
addition of the stacking gel.  For the stacking gel, we mixed 500 µL 30% bis-acrylamide 
(29:1) solution, 375 µL 1M Tris (pH = 6.8), and 1.5 µL 10% (w/v) SDS in a 10 mL tube.  
This was filled to 3 mL, vortexed, and then we added 6 µL TEMED and 30 µL 10% 
APS.  This final mixture was quickly poured into the gel apparatus over the resolving gel 
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and we inserted the comb.  After 30 minutes of standing, the gel was ready for use.  We 
stored them damp at 4°C. 
When running the gel, we first prepared 1 L of a running buffer containing 40 
mM Tris (4.856 g/L) and 189 mM glycine (14.188 g/L).  We assembled the running 
apparatus as directed using a prepared gel and running buffer.  To prepare mixtures for 
running, we mixed 10 uL of protein with 5 uL of loading buffer (Biorad, 50% glycerol 
and bromophenol blue).  Typical protein concentrations were around 500 nM pCRP (57 
µg/mL of CRP).  Each well was loaded with 12 µL.  We loaded only 5 µL of a protein 
standard or ladder to a well.  The gel was run at 80 V until the sample entered the 
resolving gel, and then ran at 100 V for approximately 2.0 to 2.5 hours or until the 
bromophenol blue reached the bottom of the plate. 
To fix and silver stain the gel, the following solutions were prepared.  All required 
25 mL total per gel and were made in Millipore water: 
 Fixing solution: 50% methanol, 5% acetic acid, 12.5 µL of 37% formaldehyde 
per 25 mL. 
 Sensitizing solution: 0.02% sodium thiosulfate.  This was made fresh daily, 
and was made from a fresh 10% solution. 
 Silver stain: 0.2% silver nitrate 
 Developer solution: 6% sodium carbonate, 100 µL of 10% sodium thiosulfate 
per 25 mL, 50 µL of 37% formaldehyde per 25 mL 
 Stopping Solution: 50% methanol, 5% acetic acid 
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Once a gel was run, we removed it from the apparatus and gently pried apart the 
gel plates.  First we immersed it in 12.5 mL of fixing solution to separate the gel from the 
remaining plate.  We let it sit for 15 minutes, and then replaced the solution.  The gel was 
washed three times with 50% methanol for 8 minutes each.  Then it was immersed in 
sensitizing solution for exactly 1 minute.  This was washed three times with Millipore 
water for 20 seconds each.  The gel was stained using silver stain for 30 minutes.  Again, 
it was washed twice with Millipore water for 30 seconds each.  To develop the bands, the 
gel was immersed in developer solution until bands visibly appeared, typically around a 
minute.  This reaction was quenched with stopping solution by swirling gently.  The gel 
was rinsed with 50% methanol for 10 minutes.  One final rinse was done with Millipore 
water.  The gel was imaged immediately, but it can be stored at 4°C in a damp container 
if desired. 
The electrophoretic migration of free 3′Cy5-RNA and bound CRP-3′Cy5-RNA 
complex were observed using nearinfrared (NIR) imaging of the wet gel using the 700 
nm channel on an Odyssey imager and CRP protein was visualized by subsequent silver 
staining of the same gel.  The binding affinity of the RNA aptamer to CRP was analyzed 
using an EMSA. Increasing amounts of 3′Cy5-RNA (0.48-3.8 μM final concentration) 
were incubated with CRP (fixed at 23 μg/mL) in binding buffer for 20 min at room 
temperature before electrophoresis.  The CRP–aptamer complex was loaded on a 5% 
polyacrylamide gel (19:1) in 0.5×TBE (45 mM Tris, 45 mM boric acid, and 1 mM 
EDTA) and electrophoresed at 110 V for 40 min at 25 °C. 
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Confocal Microscopy 
Confocal microscopy was performed using an Olympus FV1000 laser scanning 
confocal microscope using a 100x oil objective (NA = 1.4).  An excellent review of 
confocal microscopy theory was published (75).  Briefly, this method of microscopy 
illuminates a small volume with laser light and collects fluorescence from the same 
volume, thus reducing out of focus light and increasing signal to noise.  In this work, we 
used three channels of fluorescence.  Red channels, typically NPs, were excited with 594 
nm diode laser; green channels with 488 nm; and blue channels with 405 nm.  Images, 
sized 512x512 pixels from a spatial area 42x42 microns squre, were taken raster-style 
using a photodiode detector, typically with a dwell time of 12.5 µs per pixel.  Laser 
power, zoom, gain, and detector sensitivity were all adjusted as needed to obtain high 
quality images.  Each channel was collected sequentially to eliminate image 
bleedthrough.  Images were analyzed in ImageJ (76). 
Resolution for this microscope is at the diffraction limit, approximately 220 nm 
for red emission light, centered at 610 nm.  For fluorescein, the diffraction limit is 
approximately 185, centered on 516 nm.  The exact equation to calculate the absolute 
diffraction limit is: 
       
 
    
    (Eqn. 3) 
where λ is the wavelength of the observed light and NA is the numerical aperture of the 
collecting objective.  For our system, the NA is 1.4.  This distance, d, is the minimum 
size of an airy disc from the peak to the first diffraction minimum.  If two emission 
sources were closer than d in space, the central maxima of their airy discs would overlap, 
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making resolution of the sources impossible.  We define resolution as the minimum 
distance the centers of two spots must be from each other to be considered distinct spots.  
Spots in this work are defined as a 12 pixel area.  This is a circle with a 320 nm diameter.  
Our spot size conservatively presumes a size slightly larger than this absolute optical 
minimum.  If the airy disc is approximated as a Gaussian instead of a Bessel function, our 
collection diameter would collect 97% for red emission light and >99% for green 
emission light. 
Confocal microscopy was also used for fluorescence recovery after 
photobleaching (FRAP) studies.  In this method, a selected area is illuminated with the 
appropriate laser at high power, typically 100%, to bleach the local fluorophores.  The 
changes to the spatial distribution of bleached and unbleached fluorophores indicate 
fluorophore movement, and thus can be used to examine membrane fluidity and protein 
movement.  In this method, frames of fluorescence are taken at regular time points.  Each 
frame consists of a 512x512 set of pixels observing fluorescence from a spatial area 
42x42 microns square.  For our work, FRAP curves were typically obtained by imaging 3 
initial frames, bleaching a selected area for 5 frames or ~500 to 1000 ms, and then 
imaging 17 or 37 more frames to obtain the recovery.  All published work was measured 
for 37 frames to improve accuracy of data fitting.  Pre- and post-bleach frames were 
imaged at 2µs per pixel.  Bleached areas are circles with 125 pixel diameters.  Prior to 
analysis, all FRAP images were adjusted for overall image photobleaching by correcting 
average intensity to a reference area outside the bleached area.  A correction factor was 
obtained from this outside area by dividing the average intensity at a given time point by 
 30 
the intensity in frame 1.  This factor is the percent drop in intensity due to overall image 
bleach.  The average intensity inside the FRAP area is then divided by this factor for each 
time point.  This corrects all intensities up by a sliding scale based on the total reduction. 
TIRF Microscopy 
Total internal reflection fluorescence (TIRF) microscopy is a technique that 
selectively illuminates the closest 100 nm of solution to the glass surface with an 
exponentially decaying evanescent field.  The critical angle, θc,  for total reflection is 
dependent on the difference in refractive index between the glass, n2, and water, n1, 
solution as: 
           
    
  
    (Eqn. 4) 
When the ratio of indices is less than 1, total internal reflection occurs.  The illumination 
depth is dependent on the angle of the illumination laser.  When this laser is totally 
internally reflecting, an evanescent field above the glass is created.  The rate of decay of 
this field is dependent on the angle of the illuminating laser, θ, and decays as: 
           
        (Eqn. 5) 
where 
      
  
  
   
         
         (Eqn. 6) 
The term λ0 is the wavelength of laser light in vacuum.  This method has exceptionally 
high signal-to-noise ratios, making it ideal for single particle tracking.  A full review of 
the technique was published (77).  Our experiments were performed on a Nikon Eclipse 
Ti-U equipped with a TIRF/Epifluorescence illuminator and a 60x TIRF oil objective 
(NA = 1.49).  Images were acquired using an Andor iXon EMCCD with a typical frame 
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capture time of 200 ms.  Two emission channels were available for use on this 
instrument, red and green.  Red channels were excited using a 561 nm diode laser, while 
green channels were excited using a 491 nm laser.  Channels can be imaged 
simultaneously using a DualView or sequentially using separate filter sets.  The former 
was best for tracking studies while the latter was used in static investigations.  Once 
images were collected, they were analyzed using ImageJ.  Protocol for TIRF use is in 
Appendix B. 
CRP binding to aptamer was assessed using TIRF microscopy.  Individual 
chambers were created using CoverWells (Life Technologies, Eugene, OR) that were cut 
and adhered to cleaned coverslips (No. 1 thickness, Ted Pella).  Coverslips were coated 
with monoclonal, nonspecific anti-CRP antibody (C6, 1:1,000 dilution in 30 mM sodium 
carbonate/70 mM sodium bicarbonate) for 1 h at room temperature, blocked with 3% 
BSA for 2 h, and rinsed 3× with 0.01% Tween-20/PBS buffer, and 1× with PBS.  CRP 
(mCRP or pCRP, 6 μg/mL) was preincubated with 0.3 μg/mL of 5′Cy3-RNA in binding 
buffer for 20 min at room temperature.  The samples were then added to each well, 
incubated for 10 min, rinsed 3× with 20 mM HEPES/140 mM NaCl buffer to remove 
unbound material, and imaged immediately.   Excitation of Cy3 was performed using a 
fiber launch (Solamere Technology Group, Salt Lake City, UT) equipped with an AOTF 
to shutter the excitation from a 50 mW, 561 nm diode pumped solid-state laser (Cobalt 
Jive 50, Cobalt AB, Sweden).  Emission was filtered using a 570-nm long pass dichroic 
(Omega Optical, Brattleboro, VT) and a band pass filter (605/55, Chroma Technology, 
Bellows Falls, VT).  The images were acquired on an Andor iXon EMCCD with an 
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exposure time of 200 ms and an EMgain of 200 using freely available software 
(μManager (78)). Each image was filtered using a rolling ball filter (ball radius of 10 
pixels) to eliminate background noise and correct for image tilt.  The intensity was 
integrated across the full image to obtain a reading of total fluorescence.  TIRF 
microscopy data are presented as mean ± SE from at least five independent images.  A p-
value of <0.05 using a Student’s t test was considered as significant. 
Fluorescence Assays 
Steady-state fluorescence techniques were used to illuminate changes to protein 
structure and binding.  The intrinsic fluorescence associated with tryptophan residues in 
CRP were used for these studies.  Both max intensity and peak shift will change in 
response to the solvent environment the tryptophan is in.  As residues transition from a 
hydrophobic environment to an aqueous environment, the fluorescence decreases and is 
red shifted.  CRP has 30 tryptophan residues in the native, pentameric structure making it 
a suitable candidate for fluorescence assay development.  We used fluorescence scans 
and anisotropy to investigate the unfolding of CRP.  For both assays, CRP was excited at 
280 nm and emission collected in a 5 nm window centered on 330 nm.  Scans were done 
on CRP at various stages of denaturing according to the three methods used in this work.  
In the first method, fluorescence was read at 5 minute intervals from 0 to 90 minutes 
while heating in 0.01% (w/v) SDS at 80°C.  In the second method, fluorescence was read 
for 1 M increments of concentration from 0 to 8M urea at 37°C for 2 hours.  In the final 
method, fluorescence was read for 0.2 M increments of concentration from 0 to 2.6 M 
 33 
GndHCl at 37°C for 90 minutes.  Fluorescence scans were performed on a Tecan Infinite 
M1000 plate reader using 200 μL per well. 
Anisotropy binding studies were performed on a Perkin Elmer LS55 fluorometer 
in a quartz cuvette with excitation and emission wavelengths of 555 and 570 nm and slit 
widths of 2.5 and 10 nm, respectively.  Baseline anisotropy of the 5′Cy3-RNA was 
acquired for 5 min.  Changes in anisotropy were measured after normalizing to the initial 
anisotropy of the 5′Cy3-RNA aptamer in buffer.  CRP was then added to the cuvette and 
incubated for 5 min at room temperature before anisotropy measurements were taken.  
For the displacement assay, titrations of an unlabeled ssDNA aptamer (79) were added to 
the CRP-5′Cy3-RNA complex and the measurements were taken immediately.  Final 
concentrations of CRP and 5′Cy3-RNA were 9.1 and 0.59 μg/mL, respectively.  
Tabulated data were reported as mean ± SD from three independent experiments. 
Dot blot assays were prepared to provide direct evidence of aptamer binding to 
CRP.  A 2 μL aliquot of protein was blotted on nitrocellulose membrane, air dried and 
blocked with 3% BSA+0.05% Tween-20/PBS overnight at 4 °C.  After washing 3×with 
0.005% Tween-20/PBS, the membrane was probed with 170 nM (2.38 μg/mL) 5′biotin-
RNA aptamer for 1 h at 25 °C followed by a 30-min incubation with 1:1,000 
streptavidinconjugated IR800 and imaged on an Odyssey imager (Li-COR 
Biotechnology, Lincoln, NE). 
Ministack Analysis 
Colocalization has traditionally been a difficult quantity to measure (80).  
Therefore, we developed a procedure in MATLAB, dubbed Ministack, to compare two 
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fluorescent channels.  In this procedure, one channel was designated as the standard for 
finding spots.  In this work, we used NP channels as spot standards, but any channel with 
sufficient signal-to-noise and biological justification could act as the spot standard.  In the 
standard image, spots were located by finding the local maximum in a designated size 
above a threshold.  For our work, we choose a threshold of 500 for 200 nm spots, 250 for 
100 nm spots, and 100 for 40 nm spots.  Size of spots was selected as 9 pixels.  This is 
larger than random noise, but smaller than expected for a diffraction limited spot.  A 
25x25 pixel area around this maximum is then cut out in the standard channel.  Using 
these maxima, a corresponding spatial location was cut out in the other channels.  These 
two (or more) stacks were then directly compared where each slice pair is a single spatial 
location.  To assess overall colocalization, we averaged each pixel in the 25x25 pixel 
frame across all slices to give a single, averaged, 25x25 pixel image.  These final images 
showed the average intensity over locations determined by the standard image.  If there 
was colocalization, the second (or third, etc) channels will have increased intensity in the 
center of the image.  Conversely, if there is anti-colocalization, the channels would have 
had decreased intensity in the center.  No preference would have shown an even intensity 
pattern in the non-standard channels (81).   The typical signal-to-noise associated with 
this method is approximately 300, calculated by taking the mean peak height and dividing 
by the standard deviation of the background. 
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Chapter Three: Sensor Characterization 
This chapter details the development and characterization of a novel biosensor to 
investigate the curvature sensing properties of biologically relevant molecules.  This tool 
will enable us to probe the effect of curvature independent from the chemical 
composition of the bilayer.  We achieved three main goals during the development of this 
biosensor.  First, we designed and characterized the lipid covered surface and assessed 
the fluidity of the lipid bilayer, which is the subject of this current chapter.  Second, we 
investigated the influence curvature has on sorting lipids with different head and tail 
compositions.  Finally, we applied our biosensor to C-reactive protein (CRP), a protein 
involved in inflammation, and one that potentially has curvature sensing properties.  This 
chapter focuses on the design and characterization of the biosensor. 
Using Nanoparticles to Form a Patterned Substrate 
Since particles are below the diffraction limit, we first sought to target a specific 
spot density so that red fluorescent, carboxyl-modified polystyrene NPs are isolated from 
each other and can be spatially resolved.  Stock solutions have rather narrow size 
distributions.  100 nm NPs have a reported size standard deviation of 5 nm.  At high 
nanoparticle (NP) concentrations, NPs will cluster (82) and form irregular shapes (83) 
which would give unknown protuberances to the bilayer.  Figure 11a and b show a 
typical pair of images.  Target density of NPs is between 0.05 NP/μm2 and 0.1 NP/μm2.  
At this density, a majority of spots in the NP channel are isolated NPs, which is 
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confirmed by a histogram of the average intensities of individual spots (Figure 11c).  
Intensity indicates particle size, and a monodisperse field of particles will have a narrow 
distribution.  If multiple particles are in a single spot, the intensity of the given spot 
would be a multiple of the average intensity of a single NP.  To confirm we have only 
single particles, we measured the distribution of spot intensities and analyzed the 
histogram in two ways. 
 
Figure 11: A histogram analysis of two images shows that the majority of spots are single 
NPs.  A and B) Two separate images showing the stochastic nature of NP (100 nm) 
deposition.  42x42 μm2.  C) Histogram and statistics of average intensity of fluorescence 
of individual spots. 
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In the first method, we use the t-distribution and a Student’s t-test to check if the 
observed distribution is binomial with two proposed peaks as multiples of each other.  
This second peak will be assumed to be at twice the intensity of the median of the 
primary peak.  The median is used instead of the mean to limit the effect of outliers.  
Additionally, we assume this cluster peak has the same variance as the observed peak.  
With these assumptions, a Student’s t-test can be performed.  This tells us if our observed 
peak is distinct from the hypothetical 1
st
 cluster peak.  If it is not, then we cannot assume 
that our image has a 1
st
 cluster peak.  The calculated test statistic is t = 2.83, which is 
larger than the t-statistic (=1.96 for large n, α = 0.05).  Therefore, our assumption of a 
binomial distribution is invalid.  Another way to conceptualize this result is to consider 
that only 3.5% of spots are within 1 standard deviation, σ, of the hypothetical 1st cluster 
peak.  Yet a third way is to consider that only 2.2% of spots are more than 3σ (the 
fluorescence intensity of the mean + 3σ is 1513, near the hypothetical 1st cluster peak) 
from the observed median. 
Secondly, we fit this same histogram to two separate models, once as a single 
Gaussian and once as a sum of two Gaussians.  The first model fit very well.  The 
calculated mean fluorescence was 847 ± 12.2 (95% confidence interval) with an R2 of 
0.927.  The second model failed to converge on a solution.  Even if the second model was 
constrained where the parameters of one Gaussian matched those from the first model, no 
solution was found.  With these two methods, we can conclude that the curvature of the 
lipid bilayer is determined from single particles and fluorescently marked by the locations 
of these NPs. 
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Fluid Lipids on a Patterned Surface 
Once NPs were deposited, SLBs were formed over top.  For this sensor to be a 
useful mimic of biological activity, the lipid bilayer that is formed must be fluid both in 
the flat sections and on top of nanoparticles.  Additionally, the presence of the NPs 
should not perturb the fluidity.  Fluorescence recovery after photobleaching (FRAP) is an 
ideal tool to investigate these requirements.  For this method, fluorescence is measured 
for a specific area with a known shape that has been photobleached by high intensity 
laser light.  Fluid bilayers recovered fluorescence exponentially.  Fluorescence recovery 
kinetics are well established, and an elegant mathematical description has been done 
previously to relate recovery to lipid diffusion rates (52,84).  For circular beam profiles 
with known size, the determination of diffusion constants is simplified.  The diffusion 
constant, D, is related to the square of the bleach radius, r, the half-time, τ½, and a 
constant representing motion with a specific bleach shape, γD, as 
       
 
   
        (Eqn. 7) 
For circular bleach areas, γD = 0.88.  Half-time is the time required for the recovery to 
equal half of its equilibrium value and can be calculated from a fit to the observed 
recovery.  Fitting to a single exponential can give a characteristic time constant, k, as 
                     
        (Eqn. 8) 
Ft, 0,  are values of fluorescence at a given time, initially, and equilibrium, respectively.  
Then half-time is directly calculated from the time constant as 
       
      
 
     (Eqn. 9) 
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Using these values in equation 1, D can be calculated.  Figure 12 shows a representative 
FRAP series.  Here MB-DHPE is recovering over 200 nm polystyrene NPs.  Frames were 
taken at 1 frame per 0.5 s. 
 The above technique was used on a variety of nanoparticle sizes.  Figure 13 
details results showing that NP size has no discernible impact on diffusion constants or 
percent recovery.  Three different NP sizes were used: 40, 100, and 200 nm in diameter.  
The SLB formed for these data was 98% Soy-PC and 2% MB-DHPE.  Compared to 
recovery over a flat surface, diffusion constants for all particle sizes were not 
significantly different from recovery over a flat surface (P-value > 0.19, N=15, 
ANOVA).  These diffusion constants are of the same order as diffusion constants of 
lipids seen in a typical plasma membrane.  Above the liquid crystal transition 
temperature, lipids in a plasma membrane have diffusion constants approximately 1 
μm2/s (85).  In SLBs, diffusion constants are approximately 2.0 µm2/s (53) (8).  Table 1 
shows diffusion constants of various molecules in different environments.  Our sensor is 
slightly faster than what is reported for lipids in the plasma membrane, but this is 
expected due to the lack of transmembrane and insertion proteins that slow membrane 
Figure 12: Typical series of FRAP images.  A) NP (200 nm) image.  B)  Series of 
MB-DHPE lipid images where the bleach frame is at t=0s.  Images are corrected 
for overall photobleach, which are then used to calculate relevant fluidity 
parameters.  All images are 20x20 μm2. 
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diffusion (86).  Other work with SLBs without proteins (53) report diffusion constants 
within error of our observations.  Percent recovery had no significant differences for any 
particle size either (P-value > 0.06, N=15, ANOVA).  Recoveries were high, over 90% 
for each surface, and are similar to what is seen in a typical plasma membrane (85).  This 
indicates that the presence of NPs does not change the mobile fraction. 
  
  
Figure 13: Presence of NPs does not change fluidity parameters.  A) Recovery curves are fit 
to a single exponential recovery.  B) The mobile fraction is unchanged and has low variance 
for each set of trials.  C) Diffusion constants were more varied between trials and showed a 
higher variance within trials.  No statistical significance was observed between trials.  Error 
bars are standard error. 
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It is worth considering what the minimum detectable difference is between two 
mean diffusion constants or two percent recoveries.  This will give an estimate of how 
sensitive our method is to changes in fluidity compared to a flat bilayer.  A full 
description of this type of calculation can be found in many introductory statistics books.  
A useful reference is published (87).  The minimum detectable difference in mean 
diffusion constant, θ, is dependent on the total sample size, N (or n1 + n2), the standard 
deviation, σ (assumed equivalent for two values), the ratio of sample sizes, r (or n1/n2, as 
a value greater than 1), and the test statistics for confidence levels selected for Type I and 
Type II statistical errors, tα and tβ, respectively.  These are related as,  
       
               
   
   (Eqn. 10) 
Calculating θ is a relatively straightforward operation when σ is known from our 
observed data.  Conservatively, we choose α and β values equal to 0.05.  These are 
commonly accepted minimum levels for statistical significance.  Therefore the test 
statistics are 2.145 and 1.761, respectively.  The average σ for D between all sample 
types is 0.961 μm2/s, and n = 15 for both samples.  Using these values, θ is calculated to 
be 1.37 μm2/s.  For sufficiently large data sets (n = 30 and t-values become z-values), θ 
lowers to 0.913 μm2/s.  A comparable analysis for percent recovery can be done using an 
average σ of 10.2%.  Using our conditions of n = 15, θ is 14.5%.  For sufficiently large 
data sets, θ lowers to 9.69%.  The moderately sized θ values reflect the inherent 
variability present in SLBs (53).  This analysis indicates our biosensor is moderately 
sensitive to changes in fluidity though even large data sets would be unable to detect fine 
differences in fluidity parameters. 
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Table 1: Comparison of diffusion constants from this work to literature observations.  
Uncertainty is standard deviation (95% margin of error in parentheses). 
 Experimental D (μm2/s) Reference 
Membrane lipids ~1.0 (85) 
DMPC bilayer  
w/ NBD-DMPE 
0.94 ± 0.27 (53) 
POPC bilayer 
w/ NBD-PC (C-6) 
2.61 ± 0.49 (53) 
Soy-PC 
w/ MB-DHPE 
w/o NPs 
3.70 ± 0.81 (0.41) This work 
Soy-PC 
w/ MB-DHPE 
w/ 40 nm NPs 
3.18 ± 0.93 (0.47) This work 
Soy-PC 
w/ MB-DHPE 
w/o 100 nm NPs 
3.73 ± 0.93 (0.47) This work 
Soy-PC 
w/ MB-DHPE 
w/o 200 nm NPs 
3.98 ± 1.57 (0.79) This work 
A continuous lipid membrane can be formed over NPs of different sizes allowing 
a variety of membrane curvatures to be measured simultaneously. In Figure 14, a 
continuous supported lipid bilayer with 2% MB-DHPE was formed over 100 nm and 200 
nm NPs.  Here, red fluorescent 100 nm NPs were mixed with green fluorescent 200 nm 
NPs.  However, both could be labeled with the same dye and the size could be 
determined based on fluorescence intensity (66), allowing another color channel to be 
available. The fluidity of lipids on a mixed curvature membrane was similar to flat 
membranes; both the mobile fraction (Figure 14b) and rate of diffusion (Figure 14c) are 
unaltered.  These are also compared to a surface treated with poly-l-lysine.  This 
treatment, applied after cleaning but before lipids, involves adding concentrated poly-l-
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lysine to the well. The linked lysine residues are highly positively charged and prevent 
movement of biomolecules.  This creates a nearly immobile surface. 
Determination of diffusion constants is quite sensitive to the number of frames 
used to fit against.  Initially, we fitted our FRAP data against 17 frames of recovery.  Fit 
conditions were satisfied, but the calculated half-times for these fits had unacceptably 
large margins of error, w (calculated for 95% confidence intervals).  Fitting the single 
exponential to 37 frames of recovery reduced the margin of error noticeably.  For 
example, an average fit to 17 frames for a flat MB-DHPE bilayer had an average w equal 
to 0.22 μm2/s.  Increasing the fit to 37 frames drops the half-time margin of error to 0.14 
μm2/s (n=5 for both).  This change caused our recovery time to increase from 8.8 s to 
19.2 s.  The only disadvantages of using more frames are microscope drift at long times 
and overall photobleaching at long times.  If either the microscope drifts out of focus or 
the lipids are completely bleached, a recovery curve is impossible to obtain.  Small 
deviations in these conditions can be corrected by using an area that is not exposed to the 
high intensity laser of FRAP, and determining an overall bleach factor.  This factor is 
then used to correct the FRAP area for these deviations. 
Figure 14: Multiple sizes of NP (Green, 100 nm and Red, 200 nm) are imaged in the 
same sample (panel A, 4x4 μm2).  As expected, mobile fraction (B) and diffusion 
constants (C) are unchanged.  These are also compared to poly-lysine, which makes a 
bilayer immobile.  This caused a noticeable drop in both parameters. 
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Surface Characterization and Lipid Contouring 
We designed the membrane curvature 
biosensor to contain regions of membrane curvature 
in continuum with flat membrane.  NPs of different 
diameters are deposited on a borosilicate glass 
surface to give a controlled surface topology.  To 
form a supported lipid bilayer, liposomes are 
sonicated into solution and allowed to fuse on the 
glass surface (61).  This creates isolated areas of curvature defined by single NPs.  
Liposome coverage far exceeds the coverage of NPs, so continuous bilayers are formed 
from this process.  Figure 15 shows a schematic of this biosensor, and the following 
section details our characterization of this surface. 
Our method is based on previously established SLB techniques, and these 
methods require extremely clean surfaces.  Figure 16 is a pair of AFM images showing 
the change in surface topology before and after the cleaning treatment, which includes 
cleaning with bleach, SDS, and Hellmanex, an alkaline cleaning agent.  The dirty image 
was taken on glass straight from the box.  These images were taken and processed using 
wet AFM techniques.  Surface features prior to cleaning are around 100 nm in height and 
are numerous.  After cleaning, feature size drops to 3 nm and the frequency of features 
also drops.  Note that intensity scales for the images are not the same.  Line scans below 
each image are scaled to the same value and clearly show the reduction in surface 
topology after cleaning.  Additionally, this cleaning method is not so harsh that new 
Figure 15: Schematic of our 
biosensor with multiple extents 
of curvature shown. 
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features form, like troughs or large shallow pools.  With a cleaned, low topology surface, 
the next concern would be to ensure the SLB surrounds deposited NPs.  
  
Figure 16:  AFM images show a significant drop in surface roughness after cleaning 
treatment with Hellmanex.  Dirty glass (left) has features nearly 100 nm in height.  
Cleaned glass (right) reduces feature size to 3-5 nm.  Note that contrast scales on the 
two images change to illuminate the different feature topography. 
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To detect changes to bilayer morphology in the presence of NPs, 1 micron 
particles were deposited.  These particles are larger than the diffraction limit, so a bilayer 
coated to the surface of the NPs can be directly observed.  Typically, our studies use a 
maximum diameter of 200 nm.  A rare opportunity to image three clustered 1 μm with 
confocal microscopy is seen in Figure 17.  In the red channel (Panel A), polystyrene NPs 
form a triangle pattern.  The lipid channel shows the MB-DHPE lipids forming three 
distinct circles showing the lipids intercalate between the NPs.  The diminished 
fluorescence in the middle of each ring shows that the lipids surround the NP.  Panel B 
shows the FRAP of these lipids imaged at 2 frames per second.  After bleach to 
background levels, new unbleached lipids refill the bleached areas and show the same 
pattern of fluorescent lipids wrapping around the particles.  Intercalated lipids exchange 
with external lipids.  This pattern of recovery is seen for other particles of this size. 
Lipids are also observed above the particles.  Figure 18 shows another 1 μm 
polystyrene NP at three different heights.  In the center of the particle, designated 0 nm, a 
line scan shows increased intensity on the sides, at approximately 0.9 and 1.9 microns, 
Figure 17: FRAP of large NPs show lipids surround these NPs.  A) A cluster of 
three 1 μm NPs is above the diffraction limit. B) Bleaching the lipids (t = 0s) and 
observing recovery confirms fluidity around these large NPs.  Image size is 4.5x4,5 
μm2. 
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and reduced intensity in the middle.  Taking an image 500 nm below this point shows the 
lipids converging around the base and the background intensity increasing, indicative of 
fluorescent lipids on the surface of the surrounding glass.  500 nm above the midpoint 
shows the background at non-fluorescent noise levels, less than 100 a.u., and increased, 
even intensity above the particle.  Fluorescent lipids are surrounding the NP at all points 
in the z-stack.  In conjunction with previous work (88), these results demonstrate that the 
SLB wraps around and above the NPs, and these lipids are fluid while surrounding the 
NPs. 
Using targeted fluorescence quenching of NBD, we have shown that the SLB 
formed for this biosensor is a monolayer, though not perfectly continuous.  DHPE labeled 
with NBD [2-(4-nitro-2,1,3-benzoxadiazol-7-yl)aminoethyl] can be quenched using 
sodium dithionite (68).  This is a useful method to determine if our sensor has only a 
Figure 18: Lipids cover NPs as well as surround them.  Lipids surround the NP at 
the center (center panel).  Above the 1 μm particle (right panel), a line scan shows 
that lipids cover the top of the particle.  Below the particle (left panel), lipids are 
seen merging with the surrounding flat expanse of lipids.  The red line shows the 
position of the line scan. 
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single bilayer instead of multilayers.  Figure 19 shows the integrated fluorescence 
reduction after addition of sodium dithionite.  Before the first minute, fluorescence drops 
to 50% the initial value, then the rate of drop slows.  This initial drop indicates the upper 
leaflet of the bilayer is quickly quenched.  If there was two bilayers, the initial drop in 
fluorescence would have been to approximately 75% of initial fluorescence, and even 
less for more multilayers.  However, the fluorescence continued to drop after this initial 
reduction, indicating that the bilayer formed is not a complete barrier.  Trans-bilayer 
transport of the doubly 
charged dithionite is highly 
unlikely, but pores could 
make the bilayer 
permeable.  This biosensor 
also creates a bilayer on a 
large scale, several 
millimeters.  It is highly 
likely that imperfections 
over this incredibly large 
distance permit dithionite to 
get under the bilayer. 
Fluorescent imaging in multiple channels can potentially be contaminated by 
crosstalk and bleedthrough between the various image channels.  To address these 
concerns, we conducted a series of experiments to assess the image contamination caused 
Figure 19: Fluorescence reduction after addition of sodium 
dithionite.  The quck drop to 50% indicates a single bilayer 
forms.  The gradual reduction afterwards indicates that the 
bilayer is not completely continuous over the large scale of 
several millimeters.  Arrow indicates when dithionite was 
added. 
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by these two phenomena.  In our context, crosstalk occurs when the excitation laser of 
one fluorophore overlaps significantly with the excitation spectrum of a second 
fluorophore.  Thus the second fluorophore’s emission appears to be that of the first 
fluorophore.  Bleedthrough occurs when the emission of a fluorophore excited with a 
matched laser is sufficiently strong to get past the emission optics of a competing channel 
and appear as legitimate fluorescence.  Figure 21 is a matrix showing various cross 
excitations to determine the impact of crosstalk and bleedthrough.  Here we used 200 nm 
fluorescent NPs with either red (580/605 nm) or green (505/515 nm) emission as proxies 
to determine the relative contribution for each channel.  These dyes are proprietary 
information of Life Technologies, but the spectra are known (Figure 20).  Though this 
green emission/excitation is different from the fluorophores we will use (Alexa 488 and 
Figure 20: Spectra of green dyes used in this work.  All are very similar.  Green NPs 
have a peak that is slightly red-shifted, making them more susceptible to crosstalk from 
the red channel. 
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Fluorescein), the spectra are quite similar.  The red-shift of the green NPs compared to 
Alexa-488 make the NP more susceptible to cross-talk.  Images are background 
subtracted and fluorescence measured as average fluorescence for a 7-pixel diameter 
circle at the spot location.  Nanoparticles are the most intense fluorescent objects used in 
this work, so these numbers represent the maximum bleedthrough and crosstalk that 
could occur.  In the first column, this is expected fluorescence for a NP with matched 
excitation light and matched emission channel.  “Matched” refers to the red 
channel/fluorophore excited by a 594 nm laser and the green channel/fluorophore excited 
by a 488 nm laser.  This is used as a reference for how much that emission light will 
contaminate other channels.  In the second column, bleedthrough light is assessed by 
observing fluorescence with matched excitation but mismatched emission channel.  Here, 
red has very weak bleedthrough to green (0.18%) but green has significant bleedthrough 
into red (25%).  This is expected given the overlap in spectra between these two 
fluorophores.  In the third column, crosstalk light is assessed by observing fluorescence 
with mismatched excitation light and a mismatched emission channel.  Again red has 
very weak crosstalk with green (0.36%).  Green’s crosstalk is also weak (1.8%), but more 
significant than red.  Based on these data, we choose to image sequentially, and thus 
eliminate bleedthrough as a source of contamination because the laser and the channel are 
always matched for this imaging sequence.  
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From these data, we chose red as our NP to mark curvature since it has the least 
crosstalk.  This ensures we would not mistake lipid colocalization with NP locations.  
Therefore green will be used to identify molecules of interest, and we possibly can 
mistake molecule clusters for NP locations.  This is unlikely due to the low crosstalk 
percentage and relatively high red emission.  Taking a ratio of average green crosstalk 
fluorescence with average red matched fluorescence, the ratio is still only 1.9%.  With 
matched red fluorescence 50x brighter than the crosstalk from the brightest green object 
possible, other green molecules of interest will not be mistaken for a NP.  It should be 
noted that this analysis can only ever be a proxy.  Exact bleedthrough and crosstalk 
Figure 21: Bleedthrough and crosstalk contamination by color.  Excitation/emission 
wavelengths (nm) are shown for each image.  Red NPs (top row) have very little 
contamination into other channels.  Both types of contamination are less than 0.5%.  
Green NPs (middle row) have more significant contamination, particularly as 
bleedthrough.  Ratio to matched fluorescence is shown (bottom table).  Images are 2x2 
μm2 and scaled equally. 
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values are dependent on fluorophores used and the relevant microscope settings, most 
importantly laser power and emission windows on the confocal.  Given the low values 
obtained, the similarity between proxy fluorophores and experimental fluorophores, and 
similar microscope settings, we are confident this analysis of crosstalk and bleedthrough 
is consistent for our experimental conditions.  Therefore, our conditions will be as 
follows: NPs are red (brightest), laser powers < 5%, small, nonoverlapping emission 
windows, and sequential imaging to eliminate bleedthrough. 
Controlling Chemical Composition 
A primary goal of this biosensor is to be able to control the chemical composition 
of the bilayer independent from the curvature.  By mixing lipids in chloroform prior to 
drying, different lipids are intermingled into a single bilayer and deposited after 
resuspension.  Initially, this was assumed, but Fӧrster resonance energy transfer (FRET) 
verified our lipids were intermingling during preparation.  FRET is a process where 
energy is nonradiatively transferred from a donor molecule to an acceptor molecule.  
Donor molecules have excitation/emission bands that are higher in energy than the 
acceptor molecules.  The emission band of the donor overlaps with the excitation band of 
an appropriate acceptor molecule.  This overlap permits nonradiative transfer if the 
molecules are close enough (<10 nm) and the donor is in an excited state.  Molecules 
need to be extremely close, typically 3-5 nm for most efficient transfer.  This has 
interesting implications for FRAP.  Prior to bleaching, little to no emission would be seen 
in the donor channel.  If the acceptor molecules are bleached, and thus unable to accept 
the energy transfer, the donor emission would go up during the bleach frame.  Subsequent 
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frames would show a decrease in this donor emission.  This technique is called 
fluorescence loss after photobleaching (FLAP).  If this fluorescence loss exists, then both 
lipids are in the same bilayer. 
To test our ability to mix and control the bilayer chemical composition, we tested 
the addition of a second fluorescent lipid after a film of initial composition was created.  
Bilayers were initially mixed and dried with 97.9% PC and 2% MB-DHPE (donor) via 
chloroform evaporation, and then 0.1% Fl-HDA (acceptor) was added via DMSO and 
sonicated in deposition buffer.  Percentages are final molar percents.  Our FRET studies 
of this mixture are shown in Figure 22.  When imaging these bilayers in the MB-DHPE 
channel, nearly no fluorescence was seen.  However, bleaching in the FL excitation band 
at 488 nm caused a sudden increase in fluorescence in the MB emission channel.  This 
indicates that the molecules were experiencing FRET, but the destruction of acceptor 
molecules by bleaching temporarily stopped the transfer.  
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To explore mixed mobility of lipids on curvature, we conducted an analysis of 
variance (ANOVA) analysis of the FRET and FLAP data.  This type of analysis would 
indicate if the curvature had a different effect on diffusion when molecules are mixed as 
opposed to being in a bilayer containing only one type of fluorescing lipid.  Differences 
when two types of lipid are present would arise if lipid domains form when one lipid is 
Figure 22: FLAP and FRET of mixed MB-DHPE and Fl-HDA bilayers.  A) Loss and 
recovery curves of MB-DHPE (blue) and Fl-HDA (green).  Mobility is similar for 
multiple extents of curvature.  B) MB-DHPE (acceptor) fluorescence increases when 
Fl-HDA (donor) molecules are bleached.  C) Fl-HDA fluorescence is lost when 
bleached.  Scale bar is 3 μm. 
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not miscible with the other domain.  Diffusion would be hindered.  An examination of the 
diffusion constants when these lipids are solo in a PC bilayer versus mixed in a PC 
bilayer was inconclusive.  Table 2 summarizes the diffusion constants.  An analysis using 
a 2-Way ANOVA revealed MB-DHPE diffusion was unperturbed by the presence of 
additional lipids, specifically Fl-HDA.  We defined 2 sources of variation: one as a 
change in curvature (flat, 40 nm, 100 nm), second as a change in mixing (mixed or not).  
The interaction P-value for these variables was 0.7106, as expected for independent 
variables.  The high P-value indicates that the variance is very likely due to random 
variation (71.1% chance).  This indicates that the effect of mixing the lipids has the same 
effect for MB-DHPE on any ROC.  This insignificance permits further interpretation of 
the two sources of variation.  Neither curvature nor mixing had a significant impact on 
diffusion constants (P-values > 0.40).  Diffusion of MB-DHPE is neither perturbed by 
curvature nor mixing.  However, a similar analysis of Fl-HDA for these two variables 
revealed inconclusive results.  The interaction variable was significant (P-value = 
0.0497), which does not permit interpretation of individual effects.  This indicates that the 
two variables for Fl-HDA are not independent and would imply that curvature affects the 
mixing properties of the lipids, and thus the diffusion.  As the ROC increases, diffusion 
of the sensing molecule (Fl-HDA) is more hindered at lower ROC than it is when 
diffusing alone for those same ROCs.  This result is intriguing, but should be taken with 
caution.  The FRET data here has a low number of trials, and the recovery curve is only 
fit to 17 frames.  Both of these lead to very wide confidence intervals which decrease the 
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likelihood of finding small variations, and fitting to a small number of frames can lead to 
erroneous results entirely. 
Table 2: Comparison of diffusion constants for two lipids.  Analyzing by a 2-Way 
ANOVA, MB-DHPE is unchanged by the presence of FRET.  Fl-HDA is inconclusive as 
indicated by the nonlinear changes in a mixed bilayer. 
 Diffusion Constants (μm2/s ± 95% Confidence)   
 Flat 40 nm 100 nm n 
Fit 
Frames 
MB-DHPE 
(solo) 
3.70 ± 0.41 3.72 ± 0.47 3.73 ± 0.47 All = 15 37 
Fl-HDA 
(solo) 
2.57 ± 0.14 2.32 ± 0.09 2.09 ± 0.11 All = 5 37 
MB-DHPE 
(mixed) 
3.57 ± 0.40 3.38 ± 0.34 3.41 ± 0.48 
Flat = 5 
40 = 5 
100 = 3 
17 
Fl-HDA 
(mixed) 
1.31 ± 0.16 1.18 ± 0.20 1.24 ± 0.24 
Flat = 4 
40 = 5 
100 = 3 
17 
 
To demonstrate that our biosensor is broadly useful, we incorporated lipids that 
mimic the intracellular membrane.  The intracellular leaflet of the plasma membrane in a 
healthy cell is often markedly different than the extracellular leaflet.  For example, in 
endothelial cells, nearly all phosphatidylcholine and sphingomyelin lipids are on the outer 
leaflet, while phosphatidylethanolamine and phosphatidylserine (PS) lipids are on the 
inner leaflet (89).  The early stages of apoptosis will cause PS lipids flipping to the outer 
leaflet and be exposed to extracellular proteins (10).  We were able to form stable 
bilayers using 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) at relatively high 
concentration.  Table 3 details the diffusion constants and percent recoveries of bilayers 
with increasing mole percent DOPS.  MB-DHPE is kept constant at 2%, and soy-PC is 
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reduced proportionally (Ex: For 5% PS, there is 2% MB-DHPE and 93% soy-PC).  
Recoveries were fit to 17 frames. 
Table 3: Diffusion constants (<D>) and percent recoveries (<%R>) for bilayers formed 
with DOPS. 
 
Diffusion Constants (μm2/s ± 95% Confidence) 
Percent Recoveries (% ± 95% Confidence) 
 
 Flat 40 nm 100 nm n 
5% PS - <D> 4.62 ± 0.18 5.45 ± 0.20 5.62 ± 0.79 5 
              - 
<%R> 
92 ± 2 88 ± 2 86 ± 1 5 
10% PS - <D> 5.16 ± 0.29 5.86 ± 0.60 5.80 ± 0.17 5 
              - 
<%R> 
86 ± 2 94 ± 2 88 ± 1 5 
20% PS - <D> 5.72 ± 0.19 5.46 ± 0.25 6.26 ± 0.17 5 
              - 
<%R> 
91 ± 1 93 ± 1 90 ± 1 5 
We demonstrate that our biosensor forms fluid bilayers in the presence of relatively high 
PS concentrations and that the negative charge does not interfere with bilayer fluidity or 
formation.  In future experiments, this will enable us to explore the effect of PS on 
curvature sensing, which mimics aspects of early apoptosis.  PS also has a strong 
negative charge, which could cause significant changes to protein recruitment. 
Conclusions from the Development of the Sensor 
The first major contribution of this work is the development of the biosensor 
itself.  This tool consists of isolated nanoparticles covered in an SLB with defined 
curvature independent from composition of the SLB.  Use of this tool enables efficient 
investigations into membrane curvature sensing.  The current art of curvature sensing has 
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some disadvantages, and this new biosensor overcomes many of these hindrances.  We 
demonstrate the dynamic equilibrium between lipids at a site of curvature and lipids on a 
flat surface.  The majority of our studies were done after one hour of incubation time.  
Given the diffusion constants observed, this is long enough for the system to reach 
equilibrium.  Therefore, a binding molecule, whether lipid, protein, or anything else, can 
bind anywhere on the continuum of lipids, then migrate to sites of ideal curvature.  Good 
spatial resolution is obtained from imaging individual NPs.  Fluorescent NPs identify 
sites of curvature, and easy alignment between fluorescent channels makes spatial 
correlation between species of interest and curvature straightforward.  In addition to the 
studies in presented here, this is ideal for investigating single particle motion, which is 
being pursued by other lab members. 
Composition of the bilayer is controlled separately from the curvature of the 
bilayer.  We demonstrated surfaces patterned with one type and two types of NPs, but 
this diversity can be scaled up to include a distribution of particles sizes.  Using 
fluorescence intensity as an indicator of size (66), a surface containing a range of particle 
sizes can be examined as a continuous surface with a wide variety of curvature.  The 
inherent polydispersity from using silica nanoparticles would be ideal for use with this 
biosensor.  We mixed DOPS into soy-PC bilayers at varying mole fractions.  This is 
controlled during lipid film preparation and demonstrates our ability to control 
composition independent of curvature control.  Other lipids can be added via DMSO after 
film formation. 
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Analysis of the effect of mixing was only partly conclusive.  For MB-DHPE, a 
molecule that does not sense curvature, we conclude that the presence of mixing has no 
impact on fluidity, with curvature or without.  On the other hand, the observed diffusion 
for a sensing molecule, Fl-HDA, does seem to show curvature affecting molecule mixing.  
We speculate that the cause of this interaction term could be from the change in spatial 
distribution of sensing molecules versus non-sensing molecules.  Sensing molecules, 
having an equilibrium favoring curvature, would outcompete non-sensing molecules at 
those sites.  Sensing molecules would displace non-sensing molecules causing an 
exclusion of non-sensing molecules at sites of curvature, which would impact the 
ensemble diffusion of both molecule types.  Figure 23 schematically depicts this 
speculation.  This interaction would depend on the molecule’s sensitivity to the particular 
ROC.  More sensitive molecules would have large effects on mixed diffusion.  We 
recognize that this line of research needs to be explored more fully.  Longer recovery 
times for mixed bilayers need to be measured, and single-particle studies would help 
illuminate any areas of exclusion that exist.  Overall, our results show that FRET occurs 
between MB-DHPE and Fl-HDA, and this indicates that lipids are within 10 nm of each 
other on the supported bilayer.  
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Figure 23: Potential mechanism for mixed bilayers.  Sensing molecules, in orange, 
equilibrate toward more curvature association.  As these molecules redistribute (A to B), 
they displace non-sensing molecules, in blue.  This displacement would hinder diffusion 
of sensing molecules, causing curvature to affect sensing molecules differently than non-
sensing molecules. 
Spatial dynamics are easily studied using this biosensor.  Curvature is well 
defined by the Gaussian fluorescence intensity distribution of the bright NPs, and 
multiple channels of fluorescence permit many different species to be studied.  Designed 
with TIRF microscopy in mind, the biosensor has been used to address dynamics on two 
levels, ensemble and single molecule.  FRAP is well defined as a method to assess 
mobility, and single particle tracking is an emerging technique able to study particle 
motion in fine detail.  Both levels are accessible using this biosensor.  We foresee this 
substrate as being highly useful when measuring transient interactions between lipids or 
proteins and regions of membrane curvature. 
A major disadvantage of this biosensor is that it is still hindered by the diffraction 
limit.  Resolution below ~300nm is impossible using direct imaging techniques.  
Therefore, it is impossible to distinguish between binding to negative curvature at the 
wings of a NP or the positive curvature on top of a NP.  A way to overcome this 
limitation is by using superresolution techniques (such as stochastic optical 
reconstruction microscopy (STORM) (90)).  Use of total internal reflection fluorescence 
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microscopy on the biosensor gives a signal-to-noise ratio sufficiently high for these 
techniques, and this is ongoing research in the lab. 
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Chapter Four: Lipid Sorting 
Before tackling the effect of curvature on proteins, we assessed the effect 
curvature had on lipid partitioning for some known curvature sensitive and curvature 
insensitive molecules.  Using the ministack method we developed, we assess curvature 
sensitivity by comparing lipid fluorescence at sites of curvature.  Molecules that sense 
curvature have increased fluorescence spatially coincident with nanoparticle locations; 
those that do not will have uniform fluorescence across the field of view. 
Lipids Partition to Curvature 
We use DHPE-MB as a bilayer marker.  While 
curvature does not affect the rate of diffusion or percent 
mobile fraction, it remains to be seen whether DHPE-
MB itself has curvature sensitivity.  Using a mixture 
with 98% soy-PC and 2% MB-DHPE, images were 
taken of a fluid SLB over 100 nm NPs.  Full images 
were scanned at 12.5 μs/pixel.  In Figure 24, ministack 
analysis shows that at sites of curvature, DHPE-MB 
does not have increased fluorescence and thus no 
curvature sensitivity.  The averaged image is nearly 
uniform in intensity and a line scan across the center 
shows no noticeable increase.  A line scan through the center of the image shows no 
Figure 24: DHPE-MB does not 
sense curvature.  Ministack 
analysis of lipids (rightl) shows 
no increase at 200 nm NP 
locations (left).  Line scan is 
below.  Red line indicates 
scan.  Image size is 2x2 μm2. 
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increase at sites of curvature.  This supports DHPE-MB as an appropriate choice as a 
reporter for soy-PC fluidity. 
Two other lipids have previously been shown to have curvature sensitivity, Fl-
DHPE and Fl-HDA (3).  When included in the SLB each at 2% by mole, deposited over 
100 nm NPs, and imaged, both of these lipids were more abundant at sites of curvature 
than in flat areas of the bilayer.  Fl-DHPE and Fl-HDA both show colocalization with 
regions of membrane curvature after a ministack analysis.  Red fluorescent NPs (Figure 
25a) are imaged followed by imaging of Fl-DHPE (Figure 25b) and an overlay reveals 
that most NPs accumulate Fl-DHPE (Figure 25c). To quantify the ability of regions of 
membrane curvature to bind lipids, a colocalization method was developed that involved 
finding sites of curvature using an existing automated algorithm (81) then cropping a 25 x 
25 pixel area around that region from both the green and red channels. If a green spot 
appears in the center, an interaction exists between the two differently colors species. The 
average cut out image for both lipids clearly reveals that Fl-DHPE and Fl-HDA prefer 
sites of curvature (Figure 25d).  The intensity can be quantified by plotting a line scan. 
The normalized line scan conveys the enrichment of the green fluorescent lipids for sites 
of curvature (Figure 25e). Fl-DHPE is more enriched than Fl-HDA, a single tailed lipid, 
which is consistent with previous work (3).  High lipid fluorescence not at sites of 
curvature likely are lipids associating with non-fluorescing nanoparticles. 
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Figure 25: Fluorescein labeled lipids accumulate in regions of curvature.  A-C) Images 
of the NPs (A) and Fl-DHPE (B) and an overlay (C) are shown.  Images are 6.5x6.5 
μm2.  D) To quantify the colocalization, the red NPs are located using an automated 
algorithm and a 2x2 µm
2
 region is cropped around each NP.  The same region is 
cropped out of the lipid images.  An average of all cropped images shows the 
accumulation of Fl-DHPE and Fl-HDA at regions of curvature.  Additionally, a 
randomized image of Fl-DHPE shows no accumulation.  (C) A normalized cross section 
of Fl-HDA, Fl-DHPE and a blank (containing no green fluorescent lipids) shows that 
the accumulation is not bleedthrough.  Fl-DHPE is more sensitive to curvature than Fl-
HDA. 
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As an additional negative control, we randomized the NP images for the data from 
Fl-DHPE lipids.  This scrambles any correlation the NP and lipid channels originally had.  
If the increased fluorescence at NP locations is real and not an artifact of our ministack 
method, scrambling the NP locations should give an even field of view in the final 
averaged cutout.  Using a plugin for ImageJ, JACoP (91), the NP image (Figure 26a) was 
divided up into 4x4 squares and randomized.  Figure 26b shows this new randomized 
image with an overlay on the original image (Figure 26c).  Both the original and 
randomized images were used as a basis for determining NP locations for the ministack 
procedure.  The matrix of final, averaged images (Figure 26e-h) shows the results of this 
analysis.  The randomization has no effect on the average NP image, which is to be 
expected.  Since the NP image is used to find spots, it should resolve into a single spot 
after image averaging.  However, the average lipid images show a significant change.  
After randomizing the NP image, there is no increase in lipid flouorescence at NP 
locations (Figure 26h, also in 25d). 
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Labeling only one leaflet of the bilayer results in the same spatial distribution as 
has been shown.  Our current method to mix lipids together via sonication will disperse 
fluorescent lipids to both leaflets of the SLB.  Using a method originally developed for 
cells (92), we asymmetrically labeled SLBs with Fl-HDA using fatty acid free bovine 
serum albumin (BSA).  By preloading BSA with Fl-HDA then incubating this BSA with 
the SLB, this method inserts HDA into only the outer leaflet of the SLB after the SLB is 
formed on the glass substrate.  Transbilayer flip-flop is a concern, since flip-flop for fatty 
acids is significantly faster than typical phospholipids (93).  Uncharged hexadecanoic 
acid flips with a half time of 3.5 s in egg-PC and cholesterol mixed GUVs.  However, 
Figure 26: As a negative control, randomizing the image eliminates accumulation 
seen at sites of curvature.  A-C) When overlaying an original NP image (A) with a 
randomized counterpart (B), there is no colocalization in the overlay (C).  D) Lipid 
images remain unchanged.  E-H) A matrix of Ministack analyses show a loss of 
accumulation when the randomized image is used to determine NP locations.  Image 
size for A-D is 42x42 μm2, and E-H size is 2x2 μm2. 
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fluorescein is only fluorescent when charged, which causes a significant barrier to flip-
flop.  Figure 27 show the results of these experiments.  Increases for 200 nm NPs were 
the most significant, with a 32.2% increase in fluorescence from baseline to the peak of 
the line scan.  This is similar to the increase shown in Figure 25e for Fl-HDA present in 
both leaflets over 200 nm NPs.  100 nm and 40 nm also increased 11.6% and 1.7% at the 
peak, respectively. 
 
Figure 27: Asymmetric labeling of the lipid bilayer does not change curvature sensing.  
A) An example overlay of the Fl-HDA channel and the nanoparticle channel shows 
strong colocalization in the merged image.  B) Ministack analysis of Fl-HDA.  With 
increasing ROC, the amount of colocalization increases.  All images are 2x2 μm2 and 
each channel is scaled the same.  C) Line scans of the Fl-HDA ministacks quantify 
sensing ability by plotting fluorescence intensity against position. 
Recovery Directly over Nanoparticles is Slower than Flat Areas 
Finally with regard to lipids, we have observed lipid recovery directly over NPs.  
There was a concern that since the NPs are below the diffraction limit, recovery could be 
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only surrounding the particles, and the lipids on top would not be mobile.  Using images 
from the Fl-DHPE experiments, lipids show recovered fluorescence at NP locations after 
2 minutes of recovery time, instead of the usual 15 seconds.  In panel A of Figure 28, an 
example NP with associated recovery is shown.  The increased fluorescence that is seen 
before bleaching is also seen after bleaching.  If these lipids were not mobile, they would 
not be able to recover with unbleached lipids further away (> 2 μm).  In panel B, the 
slower recovery is seen in the plotted fluorescence against a longer time scale than seen 
previously.  Fitting to a single exponential, the observed diffusion constant for this 
fluorescence directly over the sites of curvature was 0.64 ± 0.17 μm2/s (95% confidence 
interval).  The <R
2
> for this fit was 0.835 (n=5).  
To elucidate the mechanism for this reduction in diffusion constant, we chose to 
treat these data as containing two exponentials with respective k values, kl and kb, where 
kl is the k value for the lipids, and kb is the k value for any additional bilayer properties 
(Ex: defect sites or microdomains).  The model these data were fit to is: 
 
                     
                         
      (Eqn. 11) 
 
Ft, 0,  are fluorescence intensity values at a given time, initially, and equilibrium, 
respectively.  Pf is a partition term or the fractional contribution from the faster 
exponential (kl), which makes 1 minus Pf the fraction contribution from the slower 
exponential (kb).  Therefore, we fit the same data as in Figure 28b to two exponentials, 
but constrained one parameter, kl, to a constant value, 0.206 s
-1
, which corresponds to a 
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Dl = 1.72 μm
2
/s.  This value is the constant observed for Fl-DHPE on a flat bilayer.  
Figure 29 shows recovery over flat glass side by side with recovery over a NP.  With this 
constraint, the new fit converged for 4 of 5 curves with an <R
2
> of 0.880 and the average 
Figure 28: Lipids over NPs are in dynamic equilibrium with the surrounding 
lipid pool.  A) After bleaching, fluorescence recovers (left panels) at NP 
locations (right panel).  Scale bar is 1 μm. B) Directly over NP, fluorescence 
intensity (<F>) recovers after bleaching at t=0s. 
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kb for these fits was 0.036 s
-1
.  Table 5 summarizes the parameters from this model and 
other models.  This is an improvement, but an analysis using an F-test is needed to 
determine if this is a meaningful improvement in lieu of the change in model parameters.  
When increasing the number of fit parameters to a data set, the goodness of fit will 
increase and the degrees of freedom will decrease.  The F-test will robustly account for 
this decrease in degrees of freedom and allow a comparison between models.  This test is 
similar to the Student’s t-test as 
it is a test of significance, and 
the F-test becomes a 
unidirectional t-test when only 
one parameter is compared.  
The observed diffusion constant 
for kb was Db = 0.28 ± 0.20 
μm2/s.  The F-test analysis 
would indicate that, if an 
improvement is seen, the new effect is hindering recovery. 
 Using an F-test, we determined that this additional exponential term 
improves the fit in a statistically significant way.  Our null hypothesis was that the fit to 
two exponentials shows no improvement over a fit to one exponential.  Table 4 
summarizes the calculations for determining the F-statistic, which was calculated to be 
7.77.  The null model (one exponential) had 34 degrees of freedom and the alternative 
model (two exponentials) had 33 degrees of freedom.  Using these values, the calculated 
Figure 29: Averaged recovery of lipids over flat sections 
of bilayer compared to over curved sections of bilayer.  
Recovery at sites of curvature is slower than over flat 
sections. 
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P-value for this comparison was 0.0087, or a less than 1% chance that the improvement 
in fit happened by random chance. 
 
Table 4:  Statistical calculations showing the improvement in fit from a 1-exponential fit 
to a 2-exponential fit.  This F-statistic corresponds to a P-value of 0.0087. 
 Sum of 
Squares 
Degrees of 
Freedom 
Variance F-Statistic 
Improvement 
(Difference) 
0.0777 1 0.0377 7.77 
2-Exponential Fit 
(Alternative) 
0.1601 33 0.00485  
     
1-Exponential Fit 
(Null) 
0.2378 34   
 
In addition to the analysis above, we considered alternative analyses to support 
our conclusion.  1) First, we used a 2-exponential model that had no constraints, and fit 
this model to the data.  Only 3 out of 5 curves converged on a best solution, but these 
three had a good averaged R
2
 value of 0.877.  Time constant parameters from this model 
(Table 5) are in broad agreement with the parameters from the constrained model.  
However, large confidence intervals, particularly for the partition term, Pf, make an 
assessment of close agreement impossible.  2) Secondly, we assigned a model that 
included three exponentials and added two parameters, a third time constant, k3, and a 
second partition term, P2.  This model failed to converge to a solution for any curve due 
to the parameters being statistically interdependent.  This result strongly implies that the 
3-exponential model is overcomplicated for this data and that a 3
rd
 exponential is not 
present.  To further confirm this conclusion, we assigned a model using four 
exponentials.  This also failed to converge on a solution.  3) Finally, we assigned a model 
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using a distribution of exponentials and fit this to the curves.  In this model, 100 evenly 
spaced (on a log scale) time constants are selected.  The upper and lower bounds are 
calculated as the inverse of the largest and smallest observed spacing between time points 
in the observation range of the recovery: lower bound from the time between two data 
points, and the upper bound from the time between the first and last data points.  Each of 
the 100 exponentials has a partition term, Pi, and this partition term is varied until the 
sum of the squares is minimized or the best fit is obtained.  This method failed to 
converge on a best solution due to the large number of fitting parameters.  The model fits 
100 variables while the recovery curve only has 37 data points.  Even if a solution would 
be found, this model would significantly overfit the data observed. 
Table 5: Parameters to various models considered regarding fluorescence recovery over 
single nanoparticles.  Uncertainty is ±95% Confidence Intervals. 
 
kl (s
-1
) kb (s
-1
) k3 (s
-1
) Pf P2 
1-Exponential Fit 0.077±0.020 N/A N/A N/A N/A 
2-Exponential Fit 
with kl constraint 
[0.21] 0.028±0.024 N/A 0.51±0.17 N/A 
2-Exponential Fit 
without 
constraint 
0.30±0.14 0.018±0.016 N/A .37±.52 N/A 
3-Exponential Fit This model did not converge on a best solution. 
Distribution of 
Exponentials 
This model did not converge on a best solution. 
 
 
Conclusions from Lipid Sorting 
Our work has shown that bilayer curvature can provide a means for sorting lipids.  
Curvature based sorting was tested on two fluorescein labeled lipids (Fl-DHPE and Fl-
HDA) using the membrane curvature substrate designed and characterized here. On the 
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substrate containing 100 nm diameter nanoparticles coated with a lipid bilayer, Fl-DHPE 
binds with a higher density than Fl-HDA. This trend is observed in other work, where 
liposomes (d ~ 100 nm) bind approximately twice the amount of Fl-DHPE compared to a 
12 carbon fluorescein labeled fatty acid (3). Based on this previous work, the number of 
carbons was proposed to be directly related to the density of lipids that bind to membrane 
curvature, with longer chain lipids binding at higher density to regions of curvature. Our 
work supports this by showing a slight increase in binding for Fl-DHPE, a lipid with two 
16 carbon tails, relative to Fl-HDA, which has only one.  We have also shown that this 
sorting occurs when both leaflets are loaded with a sensing molecule or when only the 
outer leaflet is loaded with a sensing molecule.  These results also address potential 
criticisms regarding the lipid directly interacting with the nanoparticle and affecting 
spatial distribution.  Loading the bilayer asymmetrically eliminates fluorescent lipid-NP 
interactions. 
Our data clarify a controversy between other research (5,3) and fills in a gap.  
Theoretical work (5) indicates that lipid shape has a minimal effect on sorting into 
curvature.  In this work the curvature coupling constant, Γ, was measured for a series of 
NBD labeled phospholipids.  NBD-DHPE has a coupling constant of -2.13 nm, indicating 
a preference for negative curvature.  The following equation can be used to predict the 
enrichment of lipids at on the outer leaflet of a liposome of curvature, H: 
        
 
 
 
 
 
         (Eqn. 12) 
Where D is the thickness of a lipid bilayer and H is the curvature.   H = 0.018 nm
-1
 and D 
is 3.6 nm for PC bilayers, 49% of the DHPE lipids should be on the inner leaflet and 51% 
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on the outer leaflet.  More are on the outer leaflet merely because of the surface area 
difference.  If a lipid shows no curvature preference, this would be 47% and 53%, 
respectively.  Our observations show this difference to be much larger. 
There are three possible reasons for our disagreement with this prediction. 1) The 
shape of our substrate is not spherical.  Within a diffraction limited area, the outer leaflet 
contains both positive and negative regions of curvature.  Our dye labeled lipid is added 
during sonication and can be on either side leaflet.  It is possible that Fl-DHPE binds to 
regions of negative curvature on the inner leaflet as it curves around the top of the 
nanoparticle and on the regions of negative curvature on the outer leaflet as the lipid 
bilayer transitions from the nanoparticle to the flat supported lipid bilayer.  Under the 
fluorescence microscope this would appear as one spot, colocalized with a nanoparticle.  
2) The fluorescein label is large relative to the NBD label, which could cause the 
molecular shape of Fl-DHPE to be slightly different than that of NBD-DHPE, altering the 
curvature preference of the lipid.  Fluorescein is more hydrophilic, and due to the 
difference in structure, we speculate has significantly larger hydrodynamic radius.  Our 
data do show a difference between DHPE when labeled with fluorescein versus marina 
blue, indicating that fluorophore choice has an influence.  However, NBD, MB and 
Fluorescein head group labeled lipids are likely above the surface of the membrane, so 
the mechanism remains unclear.  3) The concentration of Fl-DHPE (2%) is much higher 
than previous work on NBD-DHPE (0.01%), which brings out different features in 
curvature sensing.  Recent work has suggested that cooperative lipid behavior can 
facilitate curvature sensing (4). 
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Given the symmetry to our sensor design, the first reason seems the most likely 
explanation for our differences.  This biosensor design neatly removes the theoretical 
differences associated with differences in surface area.  Since we see lipid increase at 
sites of curvature, our data supports the presence of another mechanism separate from 
differences in surface area.  Defect sites only occur at sites of positive curvature, and are 
a likely explanation to the differences observed in this work. 
Curvature sensing lipids (Fl-HDA and Fl-DHPE) recover more quickly on flat 
surfaces compared to these lipids directly over sites of curvature.  Our analysis supports a 
separate mechanism that is hindering lipid diffusion at sites of curvature that is not 
individual lipid diffusion.  We propose two potential mechanisms for this hindered 
diffusion.  First, defect sites (3) are consistent with these observations.  Defects are areas 
in the lipid membrane where head groups separate to reveal the hydrophobic tails.  
Movement of these sites can be conceived as similar to movement of positively charged 
holes in a doped semiconductor.  If this comparison is valid, then defect sites would have 
an independent diffusion constant that is hindered by the neck of the curved bilayer 
where there is significant negative curvature. 
Second, we consider that the extended recovery time is due to microdomain 
formation at sites of curvature.  This would limit the exchange from bleached 
fluorophores on top of the particle and fresh fluorophores in the flat areas, thus 
potentially causing the observed reduction in diffusion constant.  Indeed, large ordered 
domains do have diffusion constants on the order of what is calculated here (~0.1 μm2/s), 
but these domains are 0.3 to 3.0 μm (94).  Diffusion of domains is inversely proportional 
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to radius.  If microdomains are causing the effect seen in the current work, we predict the 
size boundary to potentially range from 25 nm up to 300 nm (the diffraction limit).  
Using the well known Saffman-Delbrück model (51), the calculated diffusion constant of 
the domains range from 0.5386 μm2/s to 0.3263 μm2/s, respectively.  This range is similar 
to our observed Db, though the largest calculated microdomain is still faster than our 
observation.  This size is also very near the diffraction limit, meaning we would likely 
see individually moving spots replace bleached fluorescence if this is the cause of our 
observed Db. 
In conclusion to this section, we have shown that lipids sort to different areas of 
our biosensor according to the curvature of that bilayer.  In congruence with previous 
work, through using our novel ministack procedure, Fl-DHPE was more sensitive than 
Fl-HDA to sensing curvature.  We also have shown that recovery at sites of curvature is 
hindered, and this hindrance could be another diffusing entity. 
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Chapter Five: C-Reactive Protein Senses Curvature 
Introduction of CRP 
C-reactive protein (CRP) is a positive acute phase protein that participates in 
activating the classical compliment immune response which, among many things, clears 
damaged tissue and dying cells.  It was first discovered by Tillett and Francis in 1930 
(95), and is named because it precipitated C-polysaccharide derived from pneumococcal 
cell walls.  Phylogeny is highly conserved, and there is no known deficiency in humans.  
It modulates complement activation in both apoptotic and necroctic cells (96,70).  
Inflamed tissue can show a thousand-fold rise in CRP levels from basal levels (97), 
which makes it risk factor for cardiovascular disease (CVD) and other inflammatory 
diseases (98).  There is growing evidence that CRP actively participates in vascular 
events and is not simply a marker.  In fact, CVD relevant studies of CRP include the 
following:  it has been shown to induce apoptosis in human endothelial cells (99), induce 
production of pro-inflammatory cytokines (100), increase foam cell production (101), 
increase phagocyte activity (96), destabilize plaque (102), and interestingly, stabilize 
plaque (96).  Other activities have also been identified (103).  Isoform conversion has 
been a subject of particular interest and has been proposed to be responsible for 
conflicting observations of pro- and anti-inflammatory effects of CRP (104,105,106,107). 
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The structure of CRP is well characterized by X-ray crystallography.  Native CRP 
is a homopentamer forming a pentagon with C5 symmetry.  The crystal structure is 
shown in Figure 30 (108).  On one face of the pentagon are binding sites for calcium and 
phophatidylcholine (PC).  PC is one target for CRP and is found in all plasma membranes 
in the body, though it does not bind ubiquitously.  This binding is dependent on calcium 
concentration, and the calcium site is near the PC site.  The opposite face binds C1q 
(109).  CRP is approximately 10 nm across the face and 3 nm thick.  Monomers are held 
together noncovalently, and each monomer has C1 symmetry. 
Isoform conversion has been implicated previously (97) as a mechanism for CRP 
binding to endothelial cells.  This work has shown the breaking up of native CRP (a 
pentamer) into subunits, deemed mCRPm (a monomer or modified subunit that is 
membrane bound).  Subunit conversion occurred at monlayers and in liposomes of egg 
PC/lyso PC, and at the plasma membrane of Jukart T cells.  Conversion also occurs with 
the disruption of the single, intra-subunit disulfide bond (110).  This disruption retains 
monomer activity, but prevents pentamer formation.  Intrinsic tryptophan fluorescence 
was shown to decrease in the presence of egg PC/lyso PC liposomes.  This indicates the 
loss of tertiary structure in pCRP as tryptophan residues were exposed to aqueous 
solvent.  Secondary structure was conserved, as demonstrated by circular dichroism 
experiments (97).  Using electron microscopy, the circular structure of pCRP was 
observed converting to individual subunits over the course of 48 hours on egg PC/lyso 
PC monolayers.  Furthermore, the neoepitope expression ratio remained constant, 
suggesting the membrane bound mCRPm retained the conformation of pCRP.  After 
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detachment from the membrane, these mCRPm molecules showed antigenicity equivalent 
to mCRP, and caused endothelial cells to generate interleukin-8 and chemokine ligand 2 
more efficiently than pCRP.  Interleukin-8 and chemokine ligand 2 are proteins that 
induce an immune response targeted to the sites of protein generation.  When reacted 
with C1q, this membrane-bound conformer showed increased binding to C1q, suggesting 
more efficient complement activation.  This work indicates strongly that the plasma 
membrane plays a significant role in CRP isoform conversion and CRP function. 
Additional research (71) has investigated the interaction between mCRP and lipid 
microdomains in endothelial cells.  Using human aortic endothelial cells (HAECs), 
researchers demonstrated an increased affinity to the cell surface and increased 
internalization speed of mCRP over native CRP.  mCRP also showed a factor of 20 
increase in maximal protein binding to the cell surface over its native counterpart.  
Binding was concentration dependent, saturable, and fit well to a single-site binding 
model.  Using egg-PC monolayers as a substitute lipid membrane, the researchers 
observed an increase in surface pressure upon addition of mCRP, which indicates the 
protein inserts into the monolayer.  As further evidence, they showed colocalization 
between fluorescein tagged mCRP with fluorescent markers that bind to lipid raft 
microdomains both in the model eggPC system and in HAECs.  The results of this study 
indicate lipid rafts as viable binding domains for mCRP.  Choloesterol is a possible 
binding partner and CRP is thought to have two cholestrol binding domains (111).  Taken 
together, these studies reveal interesting new questions to be answered regarding CRP’s 
interactions with apoptotic cells. 
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Modified CRP shows a stronger link to pro-inflammatory effects than native 
pCRP (105,112,113).  Modified CRP is generated in vivo from pCRP at membrane 
surfaces in activated platlets (112), apoptoic blebs (96), and oxidized low desnsity 
lipoprotein (97,114).  The antigenicity of the two isoforms of CRP are distinctly different 
(115,116,117), and only modified CRP shows binding to C1q and compliment activation 
in vivo (73).  In addition to its chemokine production from endothelial cells (97), mCRP 
can interact with neutrophils (104), platelets (118), and macrophages (119), cells that 
play a key role in inflammatory responses.  In neutrophils, mCRP was shown to 
upregulate adehsion molecules, which results in increased adherance to endothelium 
(113).  Slowing of neutrophils in blood vessel flow and adhesion to blood vessel walls is 
an early phase of inflammation (120).  This process is mediated by a class of molecules 
called cell adhesion molecules (120).  Conversely, pCRP  inhibits activation and 
adherance of neutrophils (121).  pCRP functions to inhibit neutrophil chemotaxis, though 
some evidence indicates mCRP does this as well, using different receptors (106).  mCRP 
interaction with platlets caused an upregulation in P-selectin, another adhesion molecule, 
which subsequently increases neutrophil aggregation (118).  pCRP attenuates these 
changes in platlets, and further inhibits platlet aggregation directly by inhibiting 
phospholipases and reducing platelet aggregation caused by platelet aggregation factor 
(122).  One study suggested (123) that structurally modified CRP promotes the uptake of 
LDL into macrophages.  Macrophages are thought to become foam cells by taking up low 
density lipoprotein (LDL) (106), a critical event in atherosclerosis.  It is unclear however 
if this structurally modified CRP is mCRP.   A second study (124) demonstrated that 
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native pCRP bound to LDL does not promote uptake.  Taken together, these results 
indicate that mCRP has a more pronounced pro-inflammatory effect than native pCRP.  
However, as is seen with neutrophils, the role of CRP isoforms can be a complex topic. 
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There are several ways that CRP could interact with the cell surface.  Small 
molecules and proteins have been identified as targets for CRP, such as PC headgroups, 
low density lipoprotein (LDL), oxidized LDL, lysoPC, and FcγRIII (71).  Although CRP 
has a PC binding site, it will not bind PC on a flat bilayer.  One study demonstrated CRP 
Figure 30: CRP crystal structure.  In native form, CRP is a pentameric protein found in 
the human bloodstream.  It binds one phosphocholine head group (grey/red structure in 
center of monomer) per monomer unit in a calcium dependent manner (Ca
2+
 is green, 
two per monomer).  Image was taken from the protein data bank (PDB Identifier: 1B09), 
and the structure was solved in this work (108). 
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will bind to highly curved, PC coated gold nanoparticles (6).  Here, CRP with Ca
2+
 
present caused a shift in the localized surface plasmon resonance signal, indicating that 
CRP directly modified the lipid structure surrounding the nanoparticle.  There was a clear 
cutoff in size, where CRP 
bound to curved PC 
membranes that were 
presented on structures 
smaller than 30 nm in 
diameter.  A consequence 
of this study is that CRP 
will recognize a PC lipid 
membrane in the absence 
of other protein receptors or lipid oxidation when at regions of high curvature.  This 
result opens further questions regarding CRP since it confounds our understanding of 
CRP’s specificity.  Phosphocholine is a ubiquitous group found on the surface of all cells 
in the body, not just apoptotic ones.  Lipid rafts, often rich in PC lipids, are also not 
specific to apoptotic cells.  Some other mechanism other than presence of a ligand must 
dictate specificity.  These results imply CRP’s interaction could be related to the physical 
structure of the binding site, a possible mechanism by which CRP interacts with the 
curved blebs of apoptotic cells. 
  
Figure 31:  CRP curvature sensing is isoform specific.  
Green spots are CRP; red spots are NPs.  A) mCRP 
colocalizes with 100 nm particles.  Yellow shows strong 
colocalization.  B) pCRP does not colocalize with curvature.  
Scale bar is 5 μm. 
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Human C-Reactive Protein Isoform Recognizes Curvature 
Given the implications of CRP binding curvature, the biosensor we developed 
was an ideal method for determining if isoform changes would cause a change to CRP’s 
curvature sensitivity.  Upon treating CRP with 0.01% SDS and 70°C heat, CRP 
monomerized.  This treatment of CRP does not eliminate binding to C1q, the next protein 
in the classical complement pathway, which indicates mCRP is still an active form (125).  
mCRP preferentially bound to sites of curved bilayer whereas untreated pCRP bound to 
flat areas of bilayer.  A representative confocal image for mCRP is shown in Figure 31a.  
In the overlay, areas of yellow show strong colocalization.  In contrast, in Figure 31b, 
confocal images for pCRP are shown. These have no observable overlap in the overlay 
Figure 32: Comparison of ministacks of pCRP and mCRP at two extents of curvature.  
A) Matrix of averaged ministacks for CRP isoforms, autoscaled.  In both cases, 
mCRP colocalizes to curvature, demonstrated by the increased intensity in the center 
of the image.  Because pCRP has reduced intensity in the center, this might indicate 
curvature avoidance, but the high contrast makes these data inconclusive.  The red 
line indicates where the line scan was taken.  B) Normalized fluorescence intensity 
for line scans for the 4 ministacks.  mCRP (in blue) increases 300-400% from the 
background level.  pCRP (in green) is flat relative to the background with a possible 
dip in the center.  Images are 1x1 μm2. 
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image.  A comparison of ministack images in Figure 32 shows that even under this 
sensitive technique, no pCRP intensity is seen at locations of curvature.  Line scans of the 
mCRP data show a 300-400% increase in intensity at locations of curvature.  Averaged 
images of pCRP potentially show avoidance of the curved regions (Figure 32a), but the 
change is extremely small once normalized to the overall image intensity.  Other methods 
were explored to evaluate colocalization, but these methods were found insufficient for a 
variety of reasons.  In particular, an intriguing thresholding method (80) showed promise 
initially.  Briefly, this method assesses colocalization by comparing the pixel intensity of 
two channels in a scattergram.  It incrementally decreases a threshold for each channel 
until the Pearson coefficient of the pixels below the thresholds is 0.  Then pixels above 
the threshold are considered colocalized.  Unfortunately, this method ultimately proved 
too sensitive to background noise.  This is because individual pixels were examined, not 
features.  Due to the high sensitivity required to image CRP on the surface, pixel intensity 
for the background was sufficient enough to be considered correlated in this method. 
Single Particle Tracking 
Finally, we investigated the mobility of CRP at the single particle level using 
TIRF microscopy.  Confocal microscopy revealed the preference of curvature at the bulk 
level, but recent work has shown that ensemble and single particle measurements do not 
necessarily align (4).  Both m- and pCRP have a mixture of mobile and stationary 
particles on the surface of the biosensor.  Figure 33 shows a typical track of mCRP.  Full 
movies of trackable particles can be obtained in TIRF, and these data could elucidate 
transient interactions with curvature.  However, several areas of troubleshooting remain 
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to be explored.  These data are encouraging by showing 
proof of concept for single molecule tracking using the 
biosensor, and this line of research is being pursued by 
other members of the Knowles group. 
Characterization of Human C-Reactive Protein 
There are at least two distinct isoforms of CRP, and 
we have begun studying the different structures that arise as 
CRP unfolds.  In Figure 34, native pCRP is denatured using 
two separate methods, and the absolute tryptophan 
fluorescence measured.  Using a plate reader, we examined 
the fluorescence from the amino acid tryptophan.  This fluorescence is very sensitive to 
solvent environment changes, and fluorescence reduces when moving from a 
hydrophobic environment to a hydrophilic environment.  CRP has 30 tryptophan 
Figure 34: 
Representative track of 
pCRP moving on the 
surface of an SLB. 
Figure 33:  Two separate methods of denaturing CRP indicate a stable isoform exists 
between the native form and a fully denatured state. 
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residues, and is a good candidate for a tryptophan fluorescence assay.  With increasing 
concentration of guanidine hydrochloride or after 45 minutes, there is a distinct central 
plateau in fluorescence indicating a stable transitional state.  This central isoform does 
still bind to C1q (69), and is thought to be the active, modified form of CRP (mCRP).   
Equimolar free tryptophan has a normalized fluorescence of approximately 50%. 
CRP was detected through primary and secondary antibody binding.  We initially 
considered directly labeling CRP with a dye, but this process caused CRP to misfold to 
an unidentified, broad band on native gel.  Therefore we 
selected an antibody pair to visualize CRP.  Primary 
mouse anti-CRP was purchased from Santa Cruz 
Biotechnology and secondary goat anti-mouse 
immunoglobulin G with Alexa-488 was purchased from 
Life Technologies.  Several primary antibodies were 
tested with varying success.  The final candidate, clone 8 
(C8) from Santa Cruz, was the most consistent.  Dot blots 
(Appendix B) can be used to determine if an antibody (or 
pair) will successfully bind to a specific protein.  This is a qualitative assay where the 
protein is known.  An example dot blot in Figure 35 shows that this antibody pair we 
used does bind sufficiently to CRP.  The center spot is where CRP was dotted onto 
nitrocellulose, and after treatment with two antibodies (primary C8 and secondary), 
fluorescence is seen at the protein spot.  
  
Figure 35:  Dot blot of 
CRP shows the antibody 
pair selected binds to 
CRP. 
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Figure 36:  SLB prevents adherence and binding of non-membrane binding entities.  
Without an SLB, secondary antibodies bind to bare glass (A).  With an SLB, neither 
primary/secondary antibodies (B) or primary/secondary antibodies with BSA (C) will 
significantly bind to the surface.  Contrast is scaled the same for all images. 
Without the presence of CRP, the antibody pair does not bind to the surface of the 
biosensor.  Figure 36 shows confocal images of the antibodies without a bilayer present, 
with a bilayer, and with a bilayer and BSA.  Without a bilayer present, antibodies stick to 
the surface of the glass.  With a bilayer or with BSA present, no fluorescence is seen in 
the protein channel indicating no binding.  Therefore in the presence of CRP, we know 
that when fluorescence is seen at the bilayer surface, it is due to CRP binding, not 
antibodies only. 
Aptamer Specific to mCRP 
While antibodies are an excellent method for visualizing CRP when the isoform is 
known, a tool is needed to identify the isoform when it is not known.  CRP is notorious 
for displaying contradictory inflammatory effects, and this is attributed to the difficulty in 
identifying which isoform is at work (106).  In collaboration with researchers at the 
University of Colorado – Denver (69), we identified an RNA aptamer that specifically 
binds to mCRP and not pCRP.  The aptamer (Integrated DNA Technologies, Inc) was 
end-labeled with either Cy3 on the 5’ end (5’Cy3-RNA) or Cy5 on the 3’ end (3’Cy5-
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RNA) and stocks of aptamers were reconstituted with diethylpyrocarbonate (DEPC) 
treated water to remove nucleases and stored at -20°C until use.  The sequence for the 
RNA aptamer used in this study is as follows: 5’-GCC UGU AAG GUG GUC GGU 
GUG GCG AGU GUG UUA GGA GAG AUU GC-3’. 
Figure 37:  RNA aptamer will selectively bind to mCRP.  A) Control image with no 
CRP present.  B) mCRP is captured on the surface with a nonspecific antibody and 
aptamer is present.  C) pCRP is similarly captured in the presence of aptamer.  D) 
Comparison of integrated fluorescent intensity shows increased aptamer binding to 
mCRP compared to pCRP or the control.  Data is mean ± SEM.  Using Student’s t-test, 
**P-value <0.01 and #P-value <0.05.  Comparison of pCRP to the control showed 
similar integrated intensities (P-value > 0.20).  Scale bar is 40 μm. 
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Binding between 5’Cy 3-RNA and surface-bound CRP was analyzed using TIRF 
microscopy.  TIRF permits the selective excitation of 5’Cy3-RNA attached to the surface 
while excluding 5’Cy3-RNA in the bulk solution.  Therefore, binding events can be 
detected with low background noise by comparing the intensity and distribution of 
fluorescence spots on the surface.  Integrated fluorescence intensities (F) of each sample 
were subjected to image processing and plotted (Figure 37).  Anti-CRP antibodies were 
used as a capture method to avoid pCRP conversion associated with direct capture.  The 
integrated intensity of the 5’Cy3-RNA control on the anti-CRP antibody coated coverslip 
was 18.8 ± 0.51 (×10
6).  A significant increase in intensity was measured (ΔF = 3.2×106, 
P-value < 0.01, Student’s t-test) when mCRP-5’Cy3-RNA was added to the antibody-
coated coverslip as evident from the increase in spot density on the surface (Figure 37b).  
In contrast, addition of pCRP-5’Cy3-RNA (Figure 37c) caused a slight decrease in 
fluorescence intensity (ΔF = 1.1×106, P-value > 0.2, Student’s t-test), and the spot density 
on the surface was comparable to the 5’Cy3-RNA control (Figure 37a), demonstrating 
that 5’Cy3-RNA binds to mCRP but not pCRP. 
The specificity of the aptamer for mCRP was also supported by anisotropy and 
gel electrophoresis work done by our collaborators at the University of Colorado at 
Denver (69).  We demonstrated that an aptamer previously isolated against CRP (126) 
has a strong affinity for the mCRP isoform and does not associate with pCRP under the 
same conditions.  A solution binding analysis using fluorescence anisotropy was used to 
identify which isoforms of CRP bind to the aptamer, 5′Cy3-RNA (Figure 38).  
Fluorescence anisotropy measures the change in rotational diffusion rate of a fluorescent 
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probe and has been used to measure the interactions of biomolecules (127,6,128).  
Labeled aptamer should freely rotate and have a lower anisotropy than if it is bound to 
CRP.  Addition of mCRP (labeled mCRP-SDS in Figure 38 and mCRPSDS for the rest of 
this section for clarity between this and mCRPHCl) to the 5′Cy3-RNA aptamer resulted in 
a significant increase in anisotropy (Table 6), with a Δr of +0.097±0.019.  This is 
compared to a CRP denaturing method that eliminates the ability to activate compliment, 
mCRPHCl (129).  Addition of mCRPHCl to the 5′Cy3-RNA aptamer also resulted in a 
significant increase in anisotropy (Table 6), with a Δr of +0.107±0.016.  In contrast, when 
the same amount of pCRP was added to the 5′Cy3-RNA aptamer the Δr was +0.014 ± 
0.007 showing that the much larger pCRP had negligible affinity for the aptamer.  The 
final concentrations of 5′Cy3-RNA and CRP were 0.59 and 9.1 μg/mL, respectively.  In 
an additional control, no binding was observed between the aptamer and BSA (Figure 38) 
confirming that the interactions  observed were specific.   
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Figure 38: Solution binding analyses between 5’Cy3-RNA, CRP, and C1q using 
fluorescence anisotropy. Baseline anisotropy readings of 5’Cy3-RNA (0.59 μg/mL) were 
acquired prior to the addition of (green) mCRPSDS, (red) mCRPHCl, (yellow) pCRP or 
(blue) BSA (each at 9.1 μg/mL) at the first indicated time point. At the second indicated 
time point, an aliquot of C1q (5.8 μg/mL) was added to the CRP-aptamer complex and 
evaluated for complement activity. 
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Table 6: Degree of binding between 5’Cy3-RNA and CRP (Δr1) and between CRP and 
C1q (Δr2) determined by the change in anisotropy.  n=3, *P<0.001 compared to BSA 
control. 
Sample Δr1 (Mean ± SD) Δr1 (Mean ± SD) 
mCRPSDS 0.097* ± 0.019 0.099* ± 0.015 
mCRPHCl 0.107* ± 0.016 0.013 ± 0.009 
pCRP 0.014 ± 0.007 0.013 ± 0.008 
BSA 0.018 ± 0.005 0.009 ± 0.005 
Although the RNA aptamer recognizes both forms of mCRP, the bioactivity of 
each mCRP form was noticeably different.  Since modified CRP has been shown to 
activate complement in vivo (79), binding studies between mCRP and C1q were further 
evaluated by anisotropy to assess the biological activity of the each mCRP (Figure 38).  
The mCRPSDS isoform bound to C1q, resulting in a significant increase in anisotropy, 
with a Δr of +0.099±0.016 in the presence of 0.01% SDS (Figure 38).  This confirms that 
mCRPSDS is functional even though it is not in the pentameric form.  In contrast, 
mCRPHCl did not interact with C1q (Δr = +0.013 ± 0.009) (Figure 38) and adding the 
same concentration of SDS to mCRPHCl did not restore C1q binding, consistent with acid 
treatment resulting in complete and irreversible denaturation.  The final concentration of 
C1q in each case was 0.58 μg/mL.  In addition, ELISA confirmed that mCRPSDS bound 
C1q better than either pCRP or mCRPHCl (Figure 39).  The binding between C1q and 
mCRPSDS was twice as strong compared with that of the mCRPHCl by ELISA.  As 
expected, no binding was observed between pCRP and C1q by ELISA.  The strong 
binding between C1q and mCRPSDS suggests that CRP heated in a minimal amount of 
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SDS is likely to retain a folded structure as do other proteins at low SDS concentration 
(130).  On the other hand, the acid treatment (mCRPHCl) rendered the CRP irreversibly 
denatured (116,129) and without the ability to activate complement, which is in 
agreement with previous observations (129).  These results demonstrate that the 
mCRPSDS remains biologically active and expresses the neo-epitopes responsible for C1q 
binding which occurs through the Asp 112, Tyr 175, and His 38 residues on CRP (109).  
This also suggests that the aptamer specifically recognizes a portion of CRP that is 
Figure 39: Binding of different CRP isoforms to immobilized C1q. ELISA wells were 
coated with C1q (1μg/mL) and incubated with various modifications of CRP at 
increasing concentrations. The degree of CRP binding was detected using biotinylated 
polyclonal anti-CRP antibody (1:5000) with a streptavidin-HRP conjugate (1:10,000) 
and the absorbance of TMB substrate was measured on a plate reader at 450 nm with 
background subtraction at 620 nm. mCRPSDS was formed by heating with 0.1% SDS. 
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blocked when protomers are adjacent to each other, and that the mCRPSDS shows similar 
antigenicity to the modified CRP found in tissues and human arterial intima (73,131) that 
are relevant to biological function in complement activation.  Because of its high affinity 
to C1q, we consider the mCRPSDS as similar to the biologically relevant form of modified 
CRP.  Although both mCRPSDS and biologically modified CRP bind to C1q, additional 
study will be required to fully understand the antigenicity of mCRPSDS.  Since mCRPSDS 
appears to be a better model of modified CRP than does mCRPHCl, and because modified 
CRP and mCRPSDS both have an intact C1q binding site (97), we therefore sought to 
further characterize the interactions of the aptamer probe with mCRPSDS. 
To provide direct visual evidence of the protein–aptamer complex, we performed 
a dot blot assay and adapted standard PAGE methods for electrophoretic mobility shift 
assay (EMSA) to create an in-gel assay using a 3′Cy5-RNA and NIR imaging.  The 
5’biotin-RNA showed strong affinity for mCRP, with relatively weak binding to pCRP, 
and no affinity for BSA (Figure 40a).  To further observe the specificity of aptamer for 
mCRPSDS over pCRP, the proteins were separated by PAGE and visualized using silver 
stain (Figure 40b) and near infrared (NIR) imaging (Figure 40c).  When resolved on a 
10% polyacrylamide gel containing 0.005% SDS, pCRP showed an apparent MW of 140 
kDa and mCRPSDS had an apparent MW of 48 kDa (Figure 40b).  This high MW is 
caused by the nearly native conditions used and is in agreement with a previous study 
using the same gel conditions (132).  NIR imaging of the same gel revealed a distinct 
band at 48 kDa in the mCRPSDS and 3′Cy5-RNA co-incubated sample (Figure 40c).  This 
suggests that mCRPSDS forms a complex with 3′Cy5-RNA that has a similar mobility to 
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the protein alone. In contrast, no additional bands were observed in the pCRP + 3′Cy5-
RNA lane (Figure 40c), indicating that 3’Cy5-RNA did not form a persistent complex 
with pCRP.  To further evaluate the complex formation of mCRPSDS-3’Cy5-RNA, EMSA 
was performed using increasing concentrations of 3′Cy5-RNA into a fixed amount of 
mCRPSDS and resolved on a 5% 0.5× TBE acrylamide gel (Figure 41).  NIR EMSA gel 
showed increasing mCRPSDS-3′Cy5-RNA complex formation with increasing 3′Cy5-
RNA concentration and a difference in mobilities of the free 3′Cy5-RNA and the 
mCRPSDS-3′ Cy5-RNA complex bands (Figure 41a), confirming the formation of an 
mCRPSDS-3′Cy5-RNA complex.  Silver staining of the same gel also confirmed that the 
mCRPSDS-3′Cy5-RNA complex migrated differently than free mCRPSDS (Figure 41b), 
and the mCRPSDS-3′ Cy5-RNA complex bands from both techniques overlapped with the 
3′Cy5-RNA bands observed by NIR imaging (Figure 41c).  In contrast, migration of 
pCRP did not change in the presence of 3′Cy5-RNA and no complex was observed 
between pCRP and 3′Cy5-RNA.  Both dot blot and EMSA results clearly showed that 3′ 
Cy5-RNA interacts only with mCRPSDS and not pCRP, as indicated by a distinct 
mCRPSDS-3′Cy5-RNA complex band, visible by NIR imaging (Figure 41b).  The main 
advantage of this adapted EMSA method is that both the protein and protein–aptamer 
complex bands can be resolved on the same gel without the need to perform a Northern 
blot or the use of radioisotopes. 
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Figure 40: CRP-RNA complex formation. A) Dot blot assay was carried out by blotting 
CRP and BSA onto nitrocellulose and detected using a biotinylated aptamer (177nM) 
followed by streptavidin conjugated-IR 800 (1:1000) and imaged on an Odyssey NIR 
imager. CRP was preincubated with 3’Cy5-RNA before resolved on a 10% 
polyacrylamide gel containing 0.005% SDS. Protein bands were visualized by B) silver 
staining and the gel was imaged for 3’Cy5-RNA and CRP-3’Cy5-RNA complex using C) 
NIR imaging. 
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Figure 41: EMSA of mCRP and pCRP using 3’Cy5-RNA probe. A) In-gel visualization of 
3’Cy5-RNA and 3’Cy5-RNA-mCRP complex using NIR imaging, and B) visualization of 
CRP bands by silver staining of the same gel. C) Superimposed image of the NIR image 
and silver stain gel, highlighting the overlapping areas of the 3’Cy5-RNA-mCRP 
complex. 
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Increasing concentrations of mCRPSDS were added to 5′ Cy3-RNA to obtain a 
binding constant for RNA aptamer and mCRPSDS using anisotropy (Figure 42a).  The 
starting concentration of 5′Cy3-RNA was 0.68 μg/mL and aliquots of mCRPSDS were 
titrated into the solution.  The titration curve showed a saturation binding equilibrium 
between 5′ Cy3-RNA and mCRPSDS, starting with an initial anisotropy value of 
0.299±0.009 for the 5′Cy3-RNA probe, followed by a gradual increase in anisotropy, and 
finally reaching a maximum anisotropy of 0.381±0.007.  The data were fit using 
nonlinear least squares regression (GraphPad Prism 5).  From the fit curve, the CRP 
concentration at half-maximum was 4.34 μg/mL.  This corresponds to a Kd of 187.7 nM 
(using the MW for mCRP of 23 kDa), comparable to that of the previously reported Kd 
for this aptamer (133).
 
Figure 42: Quantitative binding studies between RNA-aptamer and mCRPSDS. A) 
Saturation binding curve of 5’Cy3-RNA aptamer (0.68 μg/mL) with increasing mCRPSDS 
concentrations. B) Competitive displacement assay with increasing concentration of 
ssDNA. Titrations of ssDNA were added to a solution containing mCRPSDS-5’Cy3-RNA 
complex (18 μg/mL mCRPSDS and 0.68 μg/mL 5’Cy3-RNA) Data represents mean ± SE, 
n=3. 
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In addition to the RNA aptamer, a second aptamer against CRP has been recently 
selected (79).  Because the ssDNA aptamer was selected against CRP bound to magnetic 
beads (79), we expected the ssDNA aptamer could also be mCRP specific and possibly 
compete for the same binding site as the RNA aptamer.  To determine if the DNA 
aptamer also binds mCRP, we performed a competitive displacement study using the 
CRP-specific ssDNA aptamer as a competitor (Figure 42b).  Increasing amounts of 
ssDNA aptamer were added to the mCRPSDS-5′Cy3-RNA complex until the anisotropy 
reached the baseline value.  The initial concentrations of the mCRPSDS and 5′Cy3-RNA 
were 18 μg/mL and 0.68 μg/mL, respectively.  The initial anisotropy of the mCRPSDS-
5′Cy3-RNA complex was 0.381±0.006 (the maximum anisotropy value) and no 
significant changes in anisotropy were detected at lower titrations of ssDNA.  After an 
initial lag phase, a decrease in anisotropy was observed and the drop in anisotropy 
proceeded to a plateau at a final minimum anisotropy of 0.288±0.01.  The competitive 
displacement data were fit to a dose-dependent Hill equation and the concentration of 
ssDNA needed to displace 50% of the 5′Cy3-RNA from the mCRPSDS-5′Cy3-RNA 
complex (EC50) was 0.83 μg/mL (GraphPad Prism).  A complete displacement of the 
5′Cy3-RNA was achieved at ssDNA concentrations greater than 1.6 μg/mL, or 
approximately 2X molar excess of the 5′Cy3-RNA.  In an inhibition assay, when ssDNA 
aptamer was added to mCRPSDS prior to the 5′Cy3 RNA aptamer addition, no change in 
anisotropy was observed (data not shown).  This competitive displacement assay 
suggested that the ssDNA has strong affinity to mCRPSDS, suggesting that both aptamers 
may bind to the same epitope on the mCRPSDS consistent with the ssDNA also being 
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specific to mCRP.  This further highlights a general problem with using SELEX to obtain 
aptamers for proteins that are prone to aggregation or conformational changes.  The bulk 
of the work done in this section was done with Dr. Min Wang. 
Conclusions on CRP Sorting 
The discussion about CRP isoforms has remained an active topic for the past 
decade (105,104,106,107).  Using a variety of methods to denature CRP, our data further 
confirm that (at least) a three state model for denaturing is appropriate (Figure 34).  
CRP’s ability to bind to C1q after denaturing to this second state, but not binding in the 
native state, implies that it is this non-native isoform that is functional at the surface of a 
cell. 
The difference in curvature sensitivity between isoforms also has implications to 
the active form at the cell surface.  As an indicator for apoptotic cell removal, CRP must 
be able to distinguish between healthy and apoptotic cells.  A defining characteristic of 
apoptotic cells is the physical change to the plasma membrane, notably the changes to 
extents of curvature.  Our data indicate that the change in CRP to this second, C1q-
binding isoform will bind to a soy-PC bilayer and recognize curvature.  Interestingly, 
CRP will bind to the membrane as a native, pentameric form, but either has no preference 
or weakly avoids curvature.  After conversion, CRP strongly binds to curvature.  This 
suggests that small scale curvature, where radii are less than 100 nm, plays a major role 
how CRP differentiates between healthy and apoptotic cells.  Other work indicates that 
pCRP will bind curvature only below ROC of 30 nm (125). 
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Finally, we identified an aptamer that will successfully differentiate between 
mCRP and pCRP.  By using this aptamer, isoforms can be distinguished in a variety of 
situations.  Our biosensor is one such opportunity, but this aptamer could be used in 
cellular studies as well.  Some studies (134) indicate that CRP could change isoform at 
the surface of cells.  This aptamer would be ideal to investigate these changes. 
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Chapter Six: Summary 
This work has outlined the development of a biosensor able to investigate the 
curvature sensing properties of lipids and proteins.  The biosensor consists of 
nanoparticles noncovalently adhered to a glass surface with a supported lipid bilayer 
formed over them.  This induces curvature in the bilayer independent of bilayer 
composition.  Using fluorescence microscopy, the amount of sensing can be assessed 
through colocalization with nanoparticles and FRAP.   This unique approach has several 
advantages over other methods currently in use.  1)  Most notably, our sensor allows 
lipids at sites of curvature to be in dynamic and ready equilibrium with lipids not at 
curvature.  2) This permits us to make conclusions based on a mimic that models large, 
flat membranes.  This is ideal for modeling the plasma membrane or large organelles.  3)  
Our sensor also offers significant control over the composition of the bilayer that is 
independent from the induced curvature.  This permits targeted investigations that could 
help unravel the interplay between curvature and lipid sorting.  4)  The heterogeneity of 
this setup allows specific sorting to ROC after initial binding to the bilayer.  5) The 
preparation is simple and quick.  6) And finally, the sensitivity of this assay is high 
enough to permit single-molecule studies.  This sensitivity is crucial to being able to 
probe kinetic effects such as cooperativity and nonergodic systems.  Rare, transient 
interactions between biomolecules could be observed. 
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Curvature influences lipid and protein interactions with bilayers.  We have shown 
that lipids partition differently in the presence of curvature and that these lipids do 
exchange with lipids in flat regions, though more slowly.  This supports other work 
indicating the presence of defect sites at areas of curvature, and we propose that these 
defect sites have an influence on lipid diffusion.  We have also shown that curvature will 
influence the isoform-dependent binding of CRP.  Pentameric CRP will bind to 
phosphocholine bilayers, but will not bind to curvature sites.  Monomeric (or modified) 
CRP will bind preferentially to sites of curvature.  This implies a mechanism for CRP 
recognition of apoptotic cells instead of healthy cells. 
Future Work 
Several opportunities exist to pursue work using this biosensor.  Currently, work 
is being done to investigate the dynamics of single lipids and to discern any cooperative 
effects that result.  We speculate, with others (4), that cooperative effects cause 
differences between single particle motion and ensemble motion.  Single particle studies 
could also illuminate any corralling effects that curvature could impart on lipid motion. 
Further investigations into mixtures of lipids, via FRET, FLAP, and FRAP, would 
provide insight into how compositions of lipids change the fluid parameters.  Phase 
transitions have an effect on lipid sorting (59), which has implications for micodomain 
activity, vesicle trafficking, and other membrane deforming processes. 
CRP recognition of apoptotic cells is being further explored by other group 
members.  Isoform conversion could have significant impacts not just on membrane 
sorting, but also on activation of other proteins.  One candidate is C1q.  This is another 
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complement protein and known binding partner to CRP.  It is the next protein in the 
pathway to complement activation.  C1q’s binding to the biosensor could be explored in 
the presence of either isoform of CRP.  C1q can bind to either PS or CRP, and it would 
be interesting to explore the curvature recognition of this protein in the presence of 
various binding partners. 
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 Appendix A: Acronyms 
AFM – Atomic force microscopy 
ANOVA – Analysis of variance 
BAR – Bin-Amphilphysin-Rys 
CRP – C-reactive protein 
CVD – Cardiovascular disease 
DEPC – Diethylpyrocarbonate 
DMSO – Dimethyl sulfoxide 
DOPS - 1,2-dioleoyl-sn-glycero-3-phospho-L-serine  
Fl -HDA – Fluorescien hexadeacanoic acid 
FLAP – Fluorescence loss after photobleaching 
Fl-DHPE – Fluorescien 1,2-Dihexadecanoyl-sn-Glycero-3-Phosphoethanolamine  
FRAP – Fluorescence recovery after photobleaching 
FRET – Föster resonance energy transfer 
GUV – Giant unilamillar vesicles 
HAEC – Human aortic endothelial cells 
MB-DHPE – Marina Blue 1,2-Dihexadecanoyl-sn-Glycero-3-Phosphoethanolamine  
mCRP – Monomeric CRP or modified CRP 
MWCO – Molecular weight cutoff 
NBD - [2-(4-nitro-2,1,3-benzoxadiazol-7-yl)aminoethyl]trimethylammonium 
NP – Nanoparticle 
PAGE – Polyacrylamide gel electrophoresis 
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PC – Phosphocholine 
pCRP – Pentameric CRP or native CRP 
ROC – Radius of curvature 
SDS – Sodium dodecyl sulfate 
SLB – Supported lipid bilayer 
SLiC – Single liposome curvature 
STORM - Stochastic optical reconstruction microscopy   
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Appendix B: Protocols 
Dot Blot Protocol 
Buffer: 
TTBS: 50 mM Tris, 0.5 mM NaCl, 0.05% Tween-20, pH 7.4 
 
Protocol: 
1. Cut a piece of nitrocellulose into a circle that will fit into the smallest  cell 
culture dish 
2. Dot onto the nitrocellulose an appropriate concentration.  Use 
approximately 10 uL.  You can blot various concentrations to gauge 
what’s needed for a Western.  A suggested concentration is less than 50 
nM. 
3. Incubate on the membrane at room temperature until the blots are dry.  
This is about an hour. 
4. Block the membrane with 5% dry milk in TTBS for 1 hour.  Pour off the 
buffer.  Keep the membrane wet for the remainder of the procedure. 
5. Incubate in primary antibody for 1 hour at 1:5000 dilution at RT in TTBS. 
6. Wash the membrane 3 times (10 minutes each) in TTBS on a rocker. 
7. Incubate in secondary antibody for 1 hour at 1:5000 dilution at RT in 
TTBS. 
8. Wash the membrane 3 times (10 minutes each) in TTBS on a rocker. 
9. Image. 
TIRF Startup Protocol 
Startup 
1. Turn on power strip behind the laser system. 
2. Wait for 2 lights to be lit steadily (no blinking) on each laser power 
supply.  These should be “Power” and “Temp Lock.” 
3. Turn on both keys if using both lasers. 
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4. Turn on the computer. 
5. Run the Micromanager program.  Hit ok to load configuration. 
6. Wait for the camera to cool down to -70˚C.  This should take 3-4 minutes.  
This can be monitored from the Device/Property Manager under the Tools 
menu. 
7. Once camera is cooled, the system is ready for imaging. 
8. The TIRF field is controlled by the knob on the front side of the black 
launch behind the microscope.  This adjusts the angle of the laser and, in 
turn, the TIRF field.  Clockwise increases laser angle of incidence; 
counterclockwise decreases laser angle. 
Other Comments 
 The objective is an oil objective.  One drop of oil is good for 3-5 
coverslips.  To clean, use ThorLabs lens paper with isopropenol.  NOT 
KIMWIPES. 
 Close the shutter on the camera (controlled from Micromanager) if the 
overhead lights are turned on for lengthy periods (more than a minute). 
 Do not use EM Gains above 300 if it can be avoided.  Most standard 
imaging (exposure times of 100ms+) do not need large EM Gains. 
 DO NOT SATURATE THE CAMERA.  This can quickly destroy the 
camera.  If it is saturated, reduce EM Gain and exposure time. 
 If there is a problem, contact Michelle in Mudd 101 (Phone:1-6698, 503-
267-2430), or Josh or Phillip in Mudd 259 (Phone: 1-2984) 
Shutdown Protocol 
1. Shut down Micromanager. 
2. Turn off both keys on the laser power supplies. 
3. Wait for 2 steady lights (no blinking).  These should be “Power” and 
“Temp Lock.” 
4. Turn off the power strip behind the laser system. 
Turn off the computer. 
